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Summary 
The Golgi complex (GC) is a central organelle of the secretory pathway. It receives and 
distributes material from and to other cellular organelles and is thus involved in basic 
cellular processes such as differentiation, cell motility or signal transduction. In 
mammalian cells the GC acquires a highly dynamic and unique morphology that 
quickly disassembles before mitosis and reassembles thereafter. The molecular 
regulators involved in these processes however remain largely elusive. 
To understand the molecular mechanisms of Golgi biogenesis and its regulation in 
detail, I used a combinatory approach of RNAi and diffraction limited laser 
nanosurgery to deplete cells of their GC and monitor its de novo biogenesis in the 
karyoplasts by time-lapse and correlative light and electron microscopy.  
To first identify proteins that could play a role in Golgi biogenesis, I screened the 
Human Protein Atlas database and chose 31 proteins localized exclusively to the GC 
and classified them based on their behaviour upon Brefeldin A (BFA) treatment of cells. 
This showed that 13 proteins behaved like Golgi enzymes and relocated to the 
endoplasmic reticulum after BFA treatment. Another 8 proteins showed Golgi matrix-
like behaviour and remained distributed throughout the cytoplasm as distinct Golgi 
remnants. The remaining 10 proteins showed a TGN/centrosome-like localisation after 
BFA treatment. Among the 18 Golgi matrix-like and TGN/centrosome-like proteins, I 
could validate the siRNA knockdown in 7 candidate proteins. Functional analysis of 
these 7 protein candidates by using laser nanosurgery to deplete the GC together with 
the target proteins and subsequent blocking their protein synthesis through RNAi 
showed an acceleration of the early phase of Golgi biogenesis upon depletion of 
GMAP210. Individual depletions of the 6 other Golgi proteins tested showed only a 
slight delay or no effect on Golgi biogenesis. However, double depletions of GRASP65 
& 55 or GRASP65 & Giantin resulted in delays in the kinetics of the early phase of Golgi 
biogenesis for several hours. Ultra-structural analyses by correlative light and electron 
microscopy showed that the double depletion of GRASP65 & 55 affected the flattening 
of Golgi cisternae, an event that occurs in the later phases of Golgi biogenesis, and 
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resulted in the accumulation of swollen cisternae even at the end of the experiments. In 
addition, the formation of complex and convoluted Golgi intermediates that usually 
occur in early phases during Golgi biogenesis was delayed or impaired in GRASP65 & 
55 double depleted cells.  
The delay in the ability to form Golgi precursors in GRASP65 & 55 double depleted 
cells shows the important role of these two Golgi matrix proteins acting in concert in 
the initial stages of the process. In contrast to the existing literature data, I could not 
identify any evidence of the involvement of GRASP65/55 in Golgi stacking during de 
novo Golgi biogenesis from my experiments. The results of this PhD work further 
suggest that, most likely there is no single master regulator for the Golgi biogenesis and 
there is a significant degree of functional redundancy among Golgi matrix proteins 
involved in the process. 
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Zusammenfassung 
Der Golgi Apparat (GA) ist ein zentrales Organell des Sekretorischen Weges. Er nimmt 
Material von anderen Organellen auf und verteilt sie an ihren Zielort. Deshalb ist der 
GA an grundlegenden zellulären Prozessen wie die Zelldifferenzierung, Zellmotilität 
oder Signalübertragung beteiligt.  In Gewebekulturzellen nimmt der GA eine 
einzigartige und dynamische Morphologie an, die unmittelbar vor der Zellteilung 
zerfällt und danach wieder aufgebaut wird. Die Regulierung beider Prozesse auf 
molekularer Ebene ist weitgehend unverstanden. 
Um die molekularen Mechanismen der Golgi Biogenese besser zu verstehen wurde in 
der vorliegenden Arbeit eine Kombination von RNA Interferenz (RNAi) und 
Beugungs-limitiertem Laserskalpell benutzt um zunächst den Golgi von Zellen zu 
entfernen und danach seine Biogenese mittels Fluoreszenzmikroskopie-basierten 
Zeitrafferaufnahmen und korrelierter Licht und Elektronenmikroskopie zu studieren. 
Um Proteine zu identifizieren die möglicherweise eine Rolle bei der Golgi Biogenese 
spielen wurde zunächst die Datenbank des „Human Protein Atlas“ Projekts durchsucht 
und 31 Proteine ausgesucht, die ausschließlich auf dem GA lokalisieren. Diese wurden 
dann anhand ihres Verhaltens nach der Behandlung von Zellen mit Brefeldin A (BFA) 
klassifiziert. Dies identifizierte 13 Proteine, die sich wie Golgi Enzyme verhalten, da sie 
sich nach BFA Behandlung zum endoplasmatischen Retikulum umverteilten. Weitere 8 
Protein verhielten sich wie Proteine der Golgi Matrix die sich nach BFA Behandlung auf 
diskrete Golgi Überreste im Zytoplasma umverteilen. Die restlichen 10 Proteine zeigten 
nach BFA Behandlung eine Verteilung wie Proteine des trans-Golgi Netzwerkes (TGN) 
oder Zentrosomen. Von den 18 Golgi Matrix- und TGN-ähnlichen Proteinen konnten 
für 7 siRNAs gefunden werden, die die Expression der entsprechenden Proteine 
unterdrücken. Funktionelle Analysen dieser 7 Proteine bei denen der GA zunächst 
mittels Laserskalpell von Zellen entfern wurde und anschließend die Neusynthese der 
entsprechenden Proteine mittels RNA Interferenz unterdrückt wurde, zeigten dass die 
Unterdrückung des Proteins GMAP210 die frühe Phase der Golgi Biogenese 
beschleunigt. Experimente mit den verbleibenden 6 Proteinen zeigten nur einen 
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geringen oder keinen Effekt auf die Golgi Biogenese. Die gleichzeitige Unterdrückung 
der Protein Synthese von GRASP65 und GRASP55 oder GRASP65 und Giantin 
verzögerte dagegen die Kinetik der Golgi Biogenese um mehrere Stunden. 
Ultrastrukturanalysen mittels korrelativer Licht- und Elektronenmikroskopie zeigten, 
dass die gleichzeitige Unterdrückung der Synthese von GRASP65 und GRASP55 einen 
Effekt auf die Abflachung der Golgi Zisternen, ein Vorgang der späten Golgi Biogenese, 
hat. Dies hatte eine Anhäufung angeschwollener Zisternen am Ende der Experimente 
zur Folge. Weiterhin war die Biogenese komplexer Golgi Vorläufer Strukturen wie sie 
in der frühen Phase der Golgi Biogenese vorkommen, durch die gleichzeitige 
Unterdrückung der Proteinsynthese von GRASP65 und GRASP55 verzögert und 
gestört. Dies zeigt die Bedeutung der Zusammenwirkung dieser beiden Proteine in der 
frühen Phase der Golgi Biogenese. Im Gegensatz zu Literaturdaten konnte anhand der 
hier vorliegenden experimentellen Daten keine Evidenz für die Funktion von 
GRASP65&55 beim Golgi „Stacking“ gefunden werden. 
Die Ergebnisse dieser Arbeit deuten darauf hin, dass es sehr wahrscheinlich kein 
„Master Regulator“ der Golgi Biogenese gibt und signifikante funktionelle 
Überlappungen zwischen Golgi Matrix Proteinen bei der Golgi Biogenese existieren. 
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1 Introduction 
 
Proteins, which are commonly described as the building blocks of life are constantly 
synthesised by cells and need to be transported to different cellular destinations to 
perform their functions. Various steps involved in the synthesis, modification and 
transportation of these proteins through membrane bound organelles are described as 
the secretory pathway. It involves a series of steps in which the proteins are transported 
from the Endoplasmic Reticulum (ER) towards the plasma membrane or other cellular 
compartments (Figure 1). 
  
Figure 1 Secretory Pathway 
Schematic representation of the secretory pathway with its membrane bound compartments. It shows the 
journey of proteins from ER to the plasma membrane via anterograde trafficking (red arrows) through 
Introduction 
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the Golgi complex. The proteins are recycled back to the ER via retrograde traffic retrograde traffic (black 
arrows). 
 
Most of the proteins are transported as vesicular structures coated with different coat 
complexes through anterograde trafficking. ER resident proteins involved in this 
process are recycled back to the ER through retrograde trafficking. The secretory 
proteins undergo various modifications during this process, making them functional 
and are transported to their respective cellular destinations. This process is highly 
conserved in eukaryotic cells and involves membrane bound organelles such as the 
Endoplasmic Reticulum (ER) and Golgi complex.  To introduce the topic of my thesis, 
this chapter will be focused on the secretory pathway and the Golgi complex. 
1.1 Anterograde and retrograde trafficking 
1.1.1 Anterograde trafficking 
Transport of proteins from the ER towards the Golgi or plasma membrane is defined as 
anterograde trafficking. In Figure 1, red arrows represent the anterograde trafficking 
and black arrows represent the retrograde trafficking. Proteins exit the ER only after 
critical quality control mechanisms that prevent the release of improperly folded 
proteins (Mancias and Goldberg 2005). Chaperones within the ER transiently associate 
with proteins and ensure their proper folding. The improperly folded proteins are 
retained by the chaperones in the ER or degraded.  
Newly synthesised proteins are concentrated by the vesicular coat complex COPII at 
the specialized ribosome free areas on the ER, called as ER exit sites (Malkus, Jiang, and 
Schekman 2002; Palade 1975). The proteins are then packaged into COPII coated 
vesicles. The formation of COPII coat is initiated by the activation of small GTPase Sar1 
by a GEF protein Sec12 (Saito et al. 1998). The activated Sar1 (Sar1-GTP) recruits 
cytoplasmic Sec23-Sec24 heterodimer through the interaction with Sec23 (Yoshihisa, 
Barlowe, and Schekman 1993). Sec23-Sec24 heterodimers bind to Sar1 and polymerise 
forming pre-budding complex, which forms the inner coat of the COPII vesicle (Figure 
2). The pre-budding complex recruits cargo proteins and then Sec13-Sec31 
heterotetramer is recruited forming the outer COPII coat (Figure 2). The formation of 
Introduction 
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COPII coated vesicles involving different coat components is depicted in the Figure 2. 
Once the COPII coated vesicles bud from the ER, the COPII coat disassembles by GTP 
hydrolysis on Sar1. This occurs with the help of GAP activity of Sec23-Sec24 and is 
accelerated by Sec13-31 (Antonny et al. 2001; Yoshihisa et al. 1993). 
 
Figure 2 COPII coat assembly 
Schematic representation of proposed model for COPII coat assembly process. Figure adapted from 
(Yorimitsu, Sato, and Takeuchi 2014). 
 
The COPII coated vesicles in mammalian cells are suggested to fuse by homotypic 
fusion to form large carriers called Vesicular Tubular Carriers (VTCs) (Stephens and 
Pepperkok 2001). The mechanisms of fusion of these vesicles for releasing COPII to 
form VTCs are not clearly understood. VTCs are transient intermediates between the 
ER and Golgi and traffic along microtubules towards the Golgi (Presley et al. 1997; 
Scales, Pepperkok, and Kreis 1997). During ER to Golgi transport VTCs are coated with 
the vesicular coat complex COPI (Scales et al. 1997; Shima et al. 1999), which is involved 
in the recycling of proteins from post ER membranes back to the ER. It is not clear 
whether VTCs later fuse with the Golgi or mature into a cis Golgi cisterna (Martínez-
Menárguez et al. 1999). In addition to VTCs a so-called ER-to-Golgi Intermediate 
Compartment (ERGIC), which is defined by localisation of ERGIC-53 to it, has been 
proposed to exist between the ER and Golgi complex. But unlike VTCs, ERGIC has been 
suggested to be a stable compartment to which the COPII coated vesicles can fuse (Ben-
Tekaya et al. 2005; Hauri et al. 2000; Schweizer et al. 1990; Stephens and Pepperkok 
2001).  
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1.1.2 Retrograde trafficking 
Proteins involved in fusion events, export factors and ER resident proteins travelling 
from ER to Golgi are recycled back to ER via COPI coated vesicles (Ballensiefen et al. 
1998; Malkus et al. 2004). This process begins with the recruitment of Arf-GEF (Arf-
Guanosine nucleotide Exchange Factor), which activates the small GTPase Arf1. Upon 
activation, Arf1 is recruited to the Golgi and initiates binding of the COPI coat complex. 
This COPI coat complex consists of seven subunits (α, β, β’, γ, δ, ε and ζ) that are 
recruited from the cytoplasm by Arf1. The two sub-complexes of α/β′/ε-COP and 
β/γ/δ/ζ-COP form outer and inner coats of the COPI complex respectively (Figure 3). 
Despite of these two sub-complexes, COPI coat is recruited en bloc to the Golgi 
membrane through direct interaction with membrane bound Arf1 (Hara-Kuge et al. 
1994). Similar to COPII, the inner coat recruits cargo proteins and once the COPI 
complex is properly assembled, vesicles pinch off from the Golgi membrane (Yu, 
Breitman, and Goldberg 2012). COPI coated vesicles containing cargo either diffuse or 
actively travel along the microtubules towards the ER (Chen et al. 2005). Similar to 
COPII, the COPI coat is usually disassembled or destabilised before fusing to the target 
compartment by the hydrolysis of Afr1 GTP. The schematic representation of COPI coat 
assembly involving various components is shown in Figure 3. 
 
Figure 3 COPI coat assembly 
Schematic representation of proposed model for COPI coat assembly process. Figure adapted from 
(Yorimitsu et al. 2014). 
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1.2 Role of Golgi apparatus in the secretory pathway 
The Golgi complex or Golgi apparatus plays a key role in the secretory pathway. It is 
also a carbohydrate factory, involved in the biosynthesis of glycolipids (Mellman and 
Simons 1992). Golgi is considered as the main contributor for post-translational 
modification of lipids and proteins (Potelle, Klein, and Foulquier 2015). The proteins are 
subjected to post-translational modifications such as glycosylation, phosphorylation, 
sulphation, proteolytic cleavage and sorted into different cellular destinations at the 
Golgi (Mellman and Simons 1992). These modifications are required for proper folding 
of the proteins and to make them functional.  
1.3 Structural organisation of the Golgi complex 
The Golgi complex is made up of flattened, membrane bound disc like structures called 
Golgi cisternae (Farquhar and Palade 1981). In most plants, fungi, flies and 
invertebrates Golgi stacks are distributed in the cytoplasm. In most lower eukaryotes, 
the Golgi complex consists of one or more discrete Golgi stacks per cell (Lowe 2011). 
However, some eukaryotic species such as Saccharomyces cerevisiae don’t have stacked 
Golgi, instead the individual cisternae are scattered throughout the cytoplasm (Preuss 
et al. 1992). In higher eukaryotes, these cisternae are arranged on top of each other to 
form a Golgi stack and in vertebrates the stacks are typically linked to form the Golgi 
ribbon located in the juxta-nuclear position (Figure 4). 
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Figure 4 Structural organisation of Golgi 
Left panel shows juxta-nuclear Golgi complex (Green) in mammalian cells indicated by an arrow head; 
N: nucleus. The right panel shows electron microscopic ultra structure of Golgi apparatus with stacks of 
cisternae linked to form a Golgi ribbon. Arrowheads show individual cisternae and vesicles are indicated 
with letter v. Scale bars: 10 µm (left) and 500 nm (right) respectively. 
 
The Golgi stack maintains a cis to trans polarity (Figure 5). The secretory proteins enter 
the Golgi through its cis side and exit through its trans side (Dunphy and Rothman 
1985). The movement of cargo proteins through the Golgi stack is not clearly 
understood and has been highly debated. There are different models proposed to 
explain this process (Glick and Luini 2011). Among them, the cisternal maturation 
model and the vesicular transport model are two main models. The first model 
proposes that the Golgi cisternae act as transient compartments for cargo to carry them 
forward. They are formed by the homotypic fusion of COPII or other ER carriers, 
gradually mature into a TGN cisterna and finally disintegrate into secretory vesicles or 
carriers (Bannykh and Balch 1997; Bonfanti et al. 1998; Mironov et al. 2003). The second 
model proposes that the cisternae are rather stable compartments through which the 
cargo moves via vesicles (Pfeffer 2010). 
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Figure 5 Polarised Golgi stack 
Golgi stack shows a cis to trans polarity. The names on the right hand side are examples of different Golgi 
proteins and their localisation in the Golgi stack. 
 
1.4 Golgi Proteins 
Golgi complex is a highly dynamic organelle and is able to rapidly disassemble and 
reassemble under physiological conditions, e.g., at the onset and end of mitosis 
respectively. This suggests the existence of molecular mechanisms to maintain its 
structure and identity (Ramirez and Lowe 2009). In agreement with this idea, early 
biochemical and morphological studies detected proteinaceous cross bridges linking 
adjacent cisternae (Cluett and Brown 1992; Franke et al. 1972; Turner and Whaley 1965). 
Fractionation experiments revealed detergent-insoluble proteinaceous structure to 
which Golgi enzymes could attach (Slusarewicz et al. 1994). These insoluble 
proteinaceous structures were suggested to form a structural scaffold or the Golgi 
matrix. Some examples of proteins associated with this structural scaffold are GM130, 
GRASP55 and GRASP65.  
Interestingly, the same proteins were found to be accumulated in cytoplasmic punctate 
structures upon treatment with Brefeldin A (BFA) (Xiang and Wang 2011). BFA is a 
fungal metabolite that inactivates the small GTPase ADP-ribosylation factor-1 (Arf1), 
prevents the membrane recruitment of COPI-coat and blocks the protein transport from 
the ER to the Golgi (Klausner, Donaldson, and Lippincott-Schwartz 1992). BFA 
treatment results in the disassembly of the Golgi and relocation of the Golgi enzymes 
GM130,	p115,	
GMAP210,	GRASP65,
Giantin,	Golgin-84,	
Golgin-160
TMF,	Golgin-97,	
BICD2,	Golgin-245,
GCC88
GRASP55,	
Golgin-45
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into the ER. The Golgi matrix proteins remain in the cytoplasm as punctate structures 
(Lippincott-Schwartz et al. 1991) and the Trans Golgi network is redistributed as a 
tubular network (Klausner et al. 1992; Wei and Seemann 2010). The effects of Brefeldin 
A treatment are reversible, hence the Golgi complex reforms upon removal of the drug. 
1.4.1 Golgi matrix proteins 
Several components of this Golgi matrix have been identified. They localise to cis, medial 
or trans cisternae of the Golgi. These Golgi matrix proteins include Golgins and 
GRASPs that play an important role in membrane traffic and structural organization of 
the Golgi. These proteins are suggested to be important in post-mitotic reassembly and 
stacking of the Golgi cisternae (Marra et al. 2001). 
Golgins are coiled coil proteins, typically anchored to Golgi membranes and mostly 
present in the cis, trans faces and on the rims the Golgi stack. Apart from their Golgi 
localisation and coiled coil domains, these proteins interact with small GTPases (Sinka 
et al. 2008). These interactions may promote their recruitment to specific Golgi 
compartment or regulate their functions. Golgins were first identified in patients 
suffering from a variety of auto-immune diseases. These proteins form homodimers 
and attach to the Golgi membranes via their Carboxy terminus (Munro 2011). The rod 
like structures formed on the surface of Golgi due to the coiled coil domains of Golgins 
are proposed to be involved in various tethering events. These tethering events include 
linking of the Golgi cisternae, Golgi stacks, capture of transport intermediates and Golgi 
elements even over relatively large distances (Waters and Pfeffer 1999). They were also 
shown to be important in maintaining Golgi integrity. The members of the Golgin 
family have diverse structure and functions. The following section includes literature 
results on the proteins studied in this project. Some of them were classified as 
mammalian Golgins (Barr and Short 2003) (GM130, GRASP55, GRASP65, Giantin and 
GMAP210) and others were identified as Golgi localized proteins (TMF1 and 
TMEM165). 
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1.4.1.1 GM130 
GM130 is a coiled coil protein localised to the Golgi complex. It was first detected 
through antisera raised to detergent and salt resistant matrix fraction from Golgi stacks 
of rat liver. It was shown to be localised to cis Golgi and was proposed to play a role in 
maintaining cis Golgi structure (Nakamura et al. 1995). It was also shown that GM130 
together with GRASP65 is necessary for the formation of Golgi ribbon in mammalian 
cells (Puthenveedu et al. 2006). There is an enormous amount of literature data on 
diverse roles of GM130 in different cellular processes till date. Some of which propose 
role of GM130 in tethering COPI coated vesicles to the Golgi via its complex with p115 
and Giantin (Alvarez et al. 2001; Linstedt et al. 2000). Other experimental evidence has 
shown that GM130 is phosphorylated during mitosis and this inhibits its binding to 
p115 and this process is reversed upon dephosphorylation (Lowe, Gonatas, and Warren 
2000). GM130 is also shown to contribute to pericentriolar localization of the Golgi 
through its interaction with the centrosome, in mammalian cells (Kodani et al. 2009). 
Depletion of GM130 has been shown to slow down the ER to Golgi traffic by transport 
studies using Vesicular Stomatitis Virus G protein (VSVG) in vivo (Diao et al. 2008). But 
this effect was not observed in BSC1 cells with the same transport assay (Tängemo et al. 
2011), which implies that this might be cell type specific. GM130 has been proposed to 
play a role in various other processes such as membrane tethering and fusion (Diao et 
al. 2008), cell polarization (Baschieri et al. 2015), migration (Nakamura 2010), spindle 
formation (Wei et al. 2015), autophagy (Chang et al. 2012), centrosome morphology 
regulation (Kodani and Sütterlin 2008) and also in developmental stages of humans 
(Shamseldin et al. 2016). Hence there is no coherent view on its role and it is 
questionable to which extent these are direct functions of GM130. So, despite of various 
proposed roles of GM130 from literature the precise function of this protein in the Golgi 
complex is not so clear.  
1.4.1.2 GRASP55 and 65 
The Golgi Re-Assembly Stacking Protein family (GRASP) includes GRASP65 and 
GRASP55, the numbers referring to their molecular mass (in KDa) on SDS PAGE. They 
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were first identified in cell free systems mimicking the mitotic disassembly and re-
assembly of Golgi complex (Barr et al. 1997). Based on experiments on cell free systems, 
they have been proposed to play a crucial role in stacking of Golgi cisternae and 
regulation of Golgi disassembly and re-assembly during mitosis (Barr et al. 1997; 
Shorter et al. 1999). Despite of being known for several years, literature results 
addressing the role of GRASPs are still very contradictory. 
GRASP65 was first identified as a target of N-ethylmaleimide (NEM), which prevents 
the mitotic reassembly of Golgi cisternae into stacked structures (Barr et al. 1997). Later 
on GRASP55 was also identified as a NEM sensitive membrane protein and is also 
shown to be required for the stacking of the cisterna (Shorter et al. 1999). It has also 
been shown that GRASP65 and 55 play an essential complementary role in cisternal 
stacking.  
Experiments performed by microinjection of GRASP65 antibodies into mitotic cells 
showed a failure to form proper Golgi stacks after cell division. Hence, GRASP65 was 
proposed to be directly involved in stacking of the Golgi cisternae (Wang et al. 2003a). 
In support to this finding, it was later shown by another group that the simultaneous 
double depletion of GRASPs resulted in a complete disassembly of the Golgi. Hence the 
GRASP55 and 65 were proposed to be involved in Golgi stacking in mammalian cells 
via a common mechanism (Y. Xiang and Wang 2010). On the contrary, RNAi 
experiments to deplete GRASP65 or GRASP55 resulted in only a reduction in number of 
cisternae per stack but the overall organization of Golgi membranes was not affected 
(Sütterlin et al. 2005). As the microinjection experiments involved IgG antibodies, there 
is a possibility that they cross-link the Golgi proteins and hence inhibit the disassembly 
of the Golgi preventing their entry into mitosis. Studies performed later also observed 
that simultaneous double depletion of GRASP65/55 resulted in disrupted cisternal 
flatness, not affecting cisternal stacking (Lee et al. 2014). They also observed that 
simultaneous depletion of GRASP65, GRASP 55 and Golgin 45 led to complete 
disassembly of Golgi stack and they suggested that the total amount of adhesive energy 
gluing the cisternae dictates Golgi cisternal stacking irrespective of the molecules 
involved in the process (Lee et al. 2014).  
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To better understand the structural role of these proteins, experiments were performed 
to obtain their crystal structures. The crystal structure showed that both of these 
proteins contain an N-terminal GRASP domain and two tandem PDZ domains with 
high sequence homology (Wang, Satoh, and Warren 2005). Further analysis of their 
crystal structures revealed homotypic interactions where GRASP domain forms a dimer 
in which peptide binding pockets of the two neighboring PDZ2 domains face each 
other. These domains are further connected by C-terminal tail of one GRASP domain 
that inserts into binding pocket of the PDZ1 domain in another dimer (Feng et al. 2013). 
Biochemical analysis showed that both these contacts are rather weak and are needed in 
combination for formation of GRASP mediated Golgi stack (Feng et al. 2013). Another 
study on the crystal structure revealed interaction of GM130 with GRASP65 via the 
PDZ domains (PDZ1 and PDZ2) of GRASP65. Based on the experimental evidence in 
this investigation, it was shown that GM130 and GRASP65 are necessary to mediate 
membrane fusion events occurring during Golgi assembly to form a Golgi ribbon (Hu 
et al. 2015).  
Along with all these conflicting structural roles of GRASPs, there are literature studies 
suggesting many diverse functions of these proteins. This include their role in 
regulating spindle dynamics (Sütterlin et al. 2005), controlling cell growth (Sütterlin et 
al. 2005), establishing cell polarity (Bisel et al. 2008), transport of receptors (D’Angelo et 
al. 2009) and sorting of cargo (Xiang et al. 2013). Recently, a GRASP65 knockout mice 
has been generated and there was no evident growth or morphological defects 
observed (Veenendaal et al. 2014). With this huge amount of contradicting and 
inconsistent data the precise role of GRASPs is still not clearly understood.  
1.4.1.3 GMAP210 
GMAP210 (Golgi Microtubule Associated Protein 210) is a peripheral Golgi protein that 
interacts with microtubules and localises at the cis Golgi. It has extensive coiled coil 
regions and hence belongs to the Golgin family of proteins. Biochemical studies 
involving lipid membranes have shown that GMAP210 is involved in connecting highly 
curved liposomes to flatter ones and this asymmetric tethering was relied on motifs that 
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sense membrane curvature. Hence it is suggested to be highly important to maintain 
Golgi structure due to rapidly changing membrane curvature during vesicular 
trafficking (Drin et al. 2008). 
It was shown that GMAP210 recruits γ-tubulin containing complexes to the Golgi 
membranes independent of Golgi localisation within the cell. Over expression of 
GMAP210 was shown to disrupt the microtubule network and induce fragmentation of 
the Golgi complex. Hence, it is proposed to participate in the maintenance and 
structural integrity of Golgi (Infante et al. 1999). However, similar effect of Golgi 
fragmentation can also observed in cells treated with Nocodazole due to the disruption 
of microtubules. Hence it is uncertain to what extent this is a direct effect in case of 
GMAP210.  
The role of GMAP210 in anterograde and retrograde trafficking has also been highly 
debated. One study showed that depletion of GMAP210 disrupts the Golgi ribbon 
leaving the Golgi stack and trafficking unperturbed (Ríos et al. 2004; Yadav, Puri, and 
Linstedt 2009), while the other studies reported that its overexpression results in 
blockage of trafficking (Friggi-Grelin, Rabouille, and Therond 2006; Pernet-Gallay et al. 
2002). Another recent study showed that depletion of GMAP210 resulted in loss of 
Golgi cisternae and accumulation of vesicles (Sato et al. 2014). This protein has also 
been implicated to play a role in linking the Golgi to the centrosome (Ríos et al. 2004) 
and ciliogenesis (Follit et al. 2008). Taken together, all the uncertain and conflicting 
experimental evidence makes the role of this protein still unclear. 
1.4.1.4 Giantin/GOLGB1 
Giantin was identified as a Golgi localised and well conserved macro Golgin (Seelig et 
al. 1994) appeared to be an integral component of the Golgi membrane. Based on its 
localisation and physical properties it is proposed to be involved in forming inter-
cisternal cross-bridges of the Golgi (Linstedt and Hauri 1993). Another study showed 
that Giantin is involved in spatial organisation of the Golgi ribbon instead of stacking. 
In this study, Giantin was exogenously expressed in Drosophila S2 cells resulting in 
clustered Golgi stacks similar to mammalian Golgi ribbon (Koreishi et al. 2013). 
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Apart from the above-mentioned structural roles of Giantin, the following are few other 
diverse functions proposed in the literature. As mentioned earlier, Giantin was shown 
to bind p115 and it was found on COPI vesicles which are docked to Golgi via GM130 
(on Golgi membranes) and p115 acting as a connecting bridge (Sönnichsen et al. 1998). 
Golgi is identified as a target organelle for certain clinical conditions such as myopathy 
(Sahashi et al. 2004), systemic lupus erythematosus and Sjögren’s syndrome (Nozawa et 
al. 2004) due to the presence of auto-antibodies for Giantin in the serum of affected 
patients. Experimental evidence also shows an important role of Giantin in ciliogenesis 
(Asante et al. 2013). Due to the lack of proper evidence for the specific role this protein 
in the Golgi complex, further investigation is necessary to clearly understand its 
function.  
1.4.1.5 TMF/ARA160 
TMF/ARA160 (TATA element Modulating Factor) was first identified and characterized 
as a co-activator for androgen receptor (AR). It was identified in many screens as a 
putative transcription factor or chromatin-remodelling factor. It was shown to be 
localised to nucleus and the Golgi complex (Mori and Kato 2002). Later on it was 
identified as an evolutionarily conserved Golgin. Depletion of TMF through RNAi 
resulted in dispersal of Golgi membranes around the cell suggesting its role in Golgi 
organization (Fridmann-Sirkis, Siniossoglou, and Pelham 2004). TMF was also shown to 
be involved in retrograde trafficking through its interaction with Rab6 (Yamane et al. 
2007). In silico analysis has shown the association of this protein with microtubules and 
thus involved in spatial orientation of Golgi (Elkis et al. 2015). This protein is also 
implicated as an essential regulator for differentiation and maturation of mammalian 
sperm (Lerer-Goldshtein et al. 2010). Due to lack of enough experimental evidence the 
role of TMF in the Golgi complex is not fully understood.  
1.4.1.6 TMEM165 
TMEM165 is a trans-membrane protein that belongs to uncharacterized protein family 
that are well conserved throughout evolution. Deficiency of this protein causes 
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Congenital Disorder of Glycosylation (CDG) (Foulquier et al. 2012).  The specific role of 
this protein in the Golgi complex has not been investigated so far.  
This protein family share common characteristics with cation/Ca2+ exchanger 
superfamily. Defects in TMEM165 showed an affect on Ca2+ and pH homeostasis. 
Hence, TMEM165 was proposed to be Ca2+/H+ antiporter and defects in this protein 
resulting in Ca2+ and pH homeostasis could explain the glycosylation defects (Demaegd 
et al. 2013). A deep intronic splice mutation of this gene results in a novel type of CDG 
(TMEM165-CDG) with bone dysplasia as a key feature (Zeevaert et al. 2013). Based on 
its expression and localisation in lactating mammary gland it was also proposed to act 
as mammary Golgi calcium transporter (Reinhardt, Lippolis, and Sacco 2014).  
1.5 Golgi Biogenesis in Mammalian cells 
Golgi is a highly dynamic organelle and it changes its architecture and shape with 
continuous trafficking events occurring across its compartments. In mammalian cells, 
during mitosis, the peripheral membrane proteins are released into the cytoplasm, the 
Golgi ribbon is disassembled and stacks of cisternae are broken down into smaller 
vesicles. In later stages of mitosis the Golgi is re-assembled and forms a functional Golgi 
complex in daughter cells. The Golgi disassembly has been proposed to act as a check-
point for the cell to enter mitosis and blockage of this process leads to cell cycle arrest in 
G2 (Colanzi and Corda 2007). The simplest explanation for the necessity of Golgi 
disassembly during mitosis is to equally distribute the Golgi ribbon among the 
daughter cells. 
1.5.1 Golgi disassembly 
The Golgi disassembly process involves unlinking the Golgi ribbon, vesiculation, 
unstacking of Golgi cisternae (Figure 6b-d), and partitioning of the Golgi into daughter 
cells (Wang and Seemann 2011). The upper panel of the Figure 6 shows the Golgi 
disassembly process with images showing the Golgi during interphase, prophase and 
pro-metaphase (Figure 6a-c). The Golgi fragmentation or ribbon unlinking during 
mitosis is achieved through Arf1 budding, independent of COPI (Misteli and Warren 
1994; Xiang et al. 2007). As mentioned earlier from literature studies, phosphorylation 
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of GRASP65 and GM130 are necessary for unstacking of Golgi during mitosis. Studies 
also showed that during mitosis the tethering complex of Giantin-p115-GM130 is 
disrupted due to phosphorylation of GM130 by Cdk1 and hence vesicles cannot fuse to 
the target membranes resulting in disruption of Golgi complex (Levine et al. 1996; Lowe 
et al. 1998). Phosphorylation of GRASP65 is regulated by plk1 and Cdk1 (Lin et al. 2000; 
Wang et al. 2003b) while GRASP55 is phosphorylated by ERK2 and Cdk1 (Jesch, Lewis, 
et al. 2001; Yi Xiang and Wang 2010a). Thus the experimental evidence shows that 
mitotic fragmentation of Golgi is achieved by the phosphorylation action of mitotic 
kinases, and vesiculation by Arf1 and COPI coat complex (Tang et al. 2008). The vesicles 
generated during this process are enriched in Golgi enzymes and SNARE proteins.  
Upon disassembly into vesicular structures, they are evenly distributed throughout the 
cytoplasm (Axelsson and Warren 2004; Jesch, Mehta, et al. 2001). At this stage it was 
also observed that a significant amount of mitotic Golgi membranes localise to spindle 
poles and associate with astral microtubules (Jokitalo et al. 2001; Seemann et al. 2002; 
Shima et al. 1998). These mitotic clusters are polarised and cis-Golgi proteins are 
spatially separated from trans similar to Golgi organisation in interphase cells (Shima et 
al. 1997). Experimental evidence also suggests that the spindle plays an important role 
in partitioning an intact Golgi between daughter cells (Wei and Seemann 2009). 
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Figure 6 Golgi disassembly and biogenesis during mitosis 
Organization of Golgi complex in different stages of mitosis showing Golgi disassembly and re-assembly. 
The upper panel shows the Golgi ribbon during interphase (a), unlinking of Golgi ribbon during early 
prophase (b), and prometaphase (c) respectively. The middle panel shows the mitotic haze during 
metaphase till anaphase (d-f). The lower panel shows Golgi re-assembly during telophase (g) and 
cytokenisis (h) proceeding towards the interphase (i). Scale bar: 10µm 
 
1.5.2 Golgi biogenesis/re-assembly 
Upon segregation into daughter cells, the mitotic Golgi membranes re-assemble during 
telophase and cytokinesis as shown in the lower panel of Figure 6g-i. Membrane fusion 
and cisternal stacking mediate the biogenesis/re-assembly process. The membrane 
fusion was shown to be achieved by SNARE proteins. They assemble on opposite 
membranes into a SNAREpin complex resulting in membrane fusion (Rothman and 
Warren 1994; Weber et al. 1998) and formation of Golgi cisternae. Disassembly of 
SNAREpin complex occurs upon membrane fusion (Müller et al. 1999). The single 
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cisternae were proposed to form Golgi stacks by de-phosphorylation of Golgi stacking 
proteins (GRASPs and GM130) mediated by protein phosphatase PP2A (Protein 
serine/threonine phosphatase type 2A). Despite of all the studies so far and various 
proteins suggested to be involved in this process, their precise role and detailed 
molecular mechanism during Golgi biogenesis is still not clearly understood. 
 
Figure 7 Models of Golgi biogenesis 
Schematic representation of two main proposed mechanisms of Golgi re-assembly/biogenesis during 
mitosis. 1.De novo assembly in which Golgi proteins produced from ER can self-organise to form a new 
Golgi that is in dynamic equilibrium with ER and 2.Template mediated assembly where a new Golgi is 
produced around a pre-existing template which is independent from the ER (Figure adapted from (Lowe 
2002)). 
 
It has been long under debate if the Golgi vesicles remain as independent structures 
and are stochastically distributed or if they are reabsorbed into the ER and partitioned 
together with ER during metaphase. Based on the evidence for these two ideas, there 
are two main proposed mechanisms for Golgi biogenesis, the de novo assembly and 
template-mediated assembly (Barr 2004) (Figure 7).  
The template-mediated assembly is based on the hypothesis that these vesicles remain 
as independent entities and serve as a template for Golgi biogenesis during mitosis 
(Axelsson and Warren 2004; Jesch, Mehta, et al. 2001; Jesch and Linstedt 1998; Jokitalo et 
al. 2001; Lucocq and Warren 1987; Terasaki 2000). The de novo assembly mechanism 
suggests that the Golgi biogenesis occurs through ER derived material that is 
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incorporated to form a new Golgi in the daughter cells (Thyberg and Moskalewski 1992; 
Zaal et al. 1999). 
1.5.3 Experimental approaches to study Golgi biogenesis 
The dynamic nature of Golgi complex allows it to rapidly change its morphology upon 
treatment with certain chemicals or molecular tools. And mostly these processes are 
reversible and can restore a functional Golgi with its original morphology. Hence these 
approaches have been used as a complement to mitosis, to study Golgi disassembly and 
re-assembly. 
1.5.3.1 Chemical approaches 
To address the question of possible template-mediated or de novo Golgi biogenesis, 
several approaches using chemical treatments have been used. One of them is treatment 
with Brefeldin A (BFA), which results in the disassembly of the Golgi and re-absorption 
of Golgi enzymes in the ER. The Golgi matrix proteins remain however in the 
cytoplasm as punctate structures. Upon washing out the drug, the Golgi is re-
assembled again forming a fully functional and intact Golgi (Kasap et al. 2004; 
Lippincott-Schwartz et al. 1989; Puri and Linstedt 2003). These findings have been 
proposed to be consistent with the de novo Golgi biogenesis. But as the Golgi matrix 
remnants remain scattered all over the cytoplasm (Seemann et al. 2000), it can also be 
possible that these Golgi remnants act as a template for Golgi biogenesis.  
Later on, experiments were performed with H89 in combination with BFA to inhibit 
COPII recruitment resulting in redistribution of Golgi matrix proteins into the ER (Puri 
and Linstedt 2003) in addition to the Golgi enzymes. The matrix proteins showed a 
faster exit from the ER upon washing out the drugs. As the Golgi matrix proteins (BFA 
remnants) were sensitive to ER blockage by H89 and re-emerge at faster rates, it was 
suggested that they cycle via the ER to the Golgi complex (Puri and Linstedt 2003), 
hence favouring the de novo biogenesis. 
Another chemical approach to address the question of Golgi biogenesis was using 
Nocodazole treatment. Nocodazole treatment of mammalian cells results in 
depolymerisation of microtubules and Golgi proteins are re-distributed into peripheral 
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mini-stacks. This has been proposed to occur via the ER and would thus provide 
evidence for Golgi de novo biogenesis (Cole et al. 1996). Another experimental approach 
used chemical inactivation of the Golgi in intact cells (Jollivet et al. 2007). Experimental 
results in this case showed the formation of a new Golgi-like structure but it could not 
acquire a normal Golgi architecture and function. Therefore template mediated Golgi 
biogenesis was favoured by this study.  
1.5.3.2 Laser nanosurgery approach to study Golgi biogenesis 
In mammalian cells, the Golgi is present in a very close proximity to the nucleus 
making it almost impossible to deplete it from cells without damaging the cell and 
nucleus. Hence, different chemical approaches (BFA, Nocodazole etc.,) mentioned 
earlier were used to address the question of Golgi biogenesis. The common drawback of 
these approaches is the inability to completely deplete the Golgi and its remnants from 
living cells. These methods can alter the distribution of the proteins or morphology of 
Golgi but are not well suited to address the question of de novo Golgi biogenesis. Hence, 
to address this question of Golgi biogenesis, our lab has developed a laser nanosurgery 
method to deplete the Golgi from intact cells and follow the karyoplasts using time-
lapse microscopy to see if it can synthesise a new Golgi (Tängemo et al. 2011).  
The Golgi is depleted by severing actin stress fibres leading to retraction of the plasma 
membrane and finally dissection of the cell into a karyoplast and Golgiplast (Figure 8). 
The karyoplasts didn’t show any Golgi like structures or stacked cisternae both in light 
and electron microscopy analysis (Tängemo et al. 2011). Except centrioles all other 
membrane organelles of the early secretory pathway including ER exit sites were 
detected in the karyoplasts (Tängemo et al. 2011).  
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Figure 8 Laser nanosurgery approach 
The panel of images show the cell subjected to laser nanosurgery. The dotted line indicates site of the 
laser nanosurgery. The Golgi complex is shown in white (GalT-GFP). Asterisk indicates the resulting 
karyoplast and arrowhead indicates Golgiplast upon laser nanosurgery. 
 
Discrete structures with GFP tagged Golgi protein appeared at 6 hr and later after the 
nano-surgery acting as transport carriers (Tängemo et al. 2011). At later time points, 
these structures started to cluster at the juxta nuclear region and colocalised with Golgi 
markers such as GM130, TGN46 and Giantin. Electron microscopic analysis of the 
karyoplasts at 12 hr or later after laser nanosurgery showed either dispersed ministacks 
or normal sized Golgi stacks. The newly synthesised Golgi was fully functional and 
transport competent. This provides strong evidence that de novo Golgi biogenesis can 
occur in mammalian cells (Tängemo et al. 2011).  
1.5.3.2.1 Detailed time-lapse analysis of Golgi biogenesis 
To understand the integration of dynamic processes such as ER export, Golgi formation 
and organization of microtubule network, a detailed time-lapse analysis of the de novo 
Golgi biogenesis after laser nanosurgery was performed.  
The quantitative analysis of Golgi biogenesis with high temporal resolution in several 
cells revealed three distinct phases of this process (Ronchi et al. 2014). In phase 1 the 
there was a steady increase in the fluorescence intensity (FI) of YFP-tagged Golgi 
enzyme marker in the ER (of karyoplast) along with small post-ER carriers being 
produced occasionally. At the ultra structural level, there was no evidence of any 
stacked Golgi like structures at this stage. The carriers produced in phase 1 were not 
very stable and they disappeared within few minutes of their formation (Figure 9). 
During the transition from phase 1 to phase 2, these small post-ER carriers collided and 
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fused with each other occasionally, resulting in the formation of more stable and larger 
structures (Ronchi et al. 2014).  
In phase 2, these structures further grew in size with exponential kinetics and started to 
attract and fuse with other smaller structures (Figure 9). Correlative Light and Electron 
Microscopic (CLEM) analysis showed larger structures formed during this phase did 
not show a typical Golgi like ultrastructure. Instead, they were clusters of juxtaposed 
membrane bound structures, which appeared to be convoluted and compact. Some 
structures in the cluster were starting to flatten acquiring cisternae like shapes 
indicative of the beginning of a stacking process.  
In phase 3, the larger structures that had formed during phase 2 clustered into a single 
structure at the juxta-nuclear location (Figure 9). CLEM analysis showed clusters of 
ministacks in phase 3 in contrast to Golgi ribbons in control cells. Based on the electron 
microscopic analysis, the formation of a stacked Golgi occurs by remodelling 
interconnected membrane precursor structures from phase 2. 
 
Figure 9 Time-lapse characterisation of de novo Golgi biogenesis 
YT2 cells were subjected to laser nanosurgery to remove the Golgi. Golgi biogenesis was then followed in 
the karyoplast by time-lapse microscopy. The images show an example of Golgi biogenesis followed at 2 
min time intervals. The four characteristic time points from the time-lapse are shown. Phase 1 shows a 
steady state accumulation of Golgi marker in the ER.  During the transition between phase 1 and phase 2, 
post ER structures were clearly visible over the ER background (marked with arrowheads). In phase 2, 
Golgi precursors become larger and brighter (white arrows). In phase 3, all the post-ER material cluster at 
a single perinuclear position (yellow arrow). Scale bar: 20µm. Figure taken from (Ronchi et al. 2014). 
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1.5.3.2.2 Dynamics and molecular composition during Golgi biogenesis 
The molecular composition of the Golgi precursors was assessed, by labelling different 
Golgi proteins at different phases of the Golgi biogenesis. The data suggests that 
different proteins associate with Golgi precursors at different time points and hence 
might contribute to different steps in the process (Ronchi et al. 2014). It was also 
observed that the Golgi matrix proteins appear much earlier than the endogenous Golgi 
enzymes during Golgi biogenesis (Tängemo et al. 2011). Also the levels of Golgi matrix 
proteins tested were dependent on the stage of the Golgi biogenesis. For example, in 
phase 2, levels of GM130, GRASP65, GRASP55 and CLASP2 were present in higher 
amounts compared to Giantin and AKAP9, which still remained low (Ronchi et al. 
2014).  
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2 Aims 
 
The question of key molecular regulators in the Golgi biogenesis process and their roles 
is still unclear. Despite of a number of Golgi proteins being known, their role and 
importance in Golgi biogenesis is far from being clearly understood.  
Here, I took advantage of our laser nanosurgery approach to achieve an acute and 
apparently complete depletion of the Golgi and its associated proteins. To prevent their 
subsequent re-synthesis during Golgi biogenesis and to understand their involvement 
in the biogenesis process, I used siRNA treatments in combination. With this 
experimental approach the main goal of my PhD project was to identify key molecular 
regulators and their roles in the Golgi biogenesis process.  
The following are specific questions I addressed in this thesis: 
1. Identify new promising candidates playing an important role in Golgi 
biogenesis, in addition to established Golgi matrix proteins. 
2. Test whether the acute depletion of selected candidates by nanosurgery and 
siRNA mediated inhibition of their re-synthesis affects the Golgi biogenesis 
process. 
3. If so, what could be the possible mechanisms by which these proteins regulate 
Golgi biogenesis? 
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3 Results 
3.1 Experimental approach to identify the regulators of Golgi 
biogenesis 
The outline of the project and experimental approach is shown in Figure 10. 
3.1.1 Classification of Golgi localised proteins using Brefeldin A treatment 
In order to identify the potential regulators of Golgi biogenesis process, I took 
advantage of the Human Protein Atlas (HPA) database (Berglund et al. 2008) that 
comprises information on spatial distribution of most of the proteins in the human 
genome. It also contains Immuno-Fluorescence (IF) images showing their localisation in 
three different cell lines. A list of 500 Golgi localised proteins was obtained from the 
HPA database. This list also includes proteins with additional localisations like 
cytoplasm, nucleus or other organelles apart from their Golgi localisation.  
These proteins with additional localisations can possibly be cargo proteins, travelling 
through the secretory pathway. Hence these proteins might not play a critical role in the 
Golgi biogenesis process. Also, the experimental approach we use to identify the role of 
the candidate proteins is laser nanosurgery in combination with RNAi to achieve an 
acute depletion of the protein. This approach can be used to acutely deplete proteins 
only that are exclusively localised to Golgi. So our main selection criterion to shortlist 
the candidate proteins (from the list of 500 proteins) was to choose proteins exclusively 
localised to the Golgi. This was done to filter out any cargo proteins that might be 
travelling through the Golgi (hence localised to the Golgi and elsewhere) and to ensure 
the acute depletion of the selected protein by our experimental approach. Among the 
500 proteins in the list, only 76 proteins were annotated to be exclusively Golgi localised 
in all the three cell lines. This list was further validated and assessed by looking at the 
IF images of each of them as they are available at the HPA data base and excluding 
proteins with additional localisations. Some of the proteins that had conflicting results 
from different experiments regarding their localisation were also excluded from the list.  
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Only a final list of 31 Golgi proteins was made, as there was limited availability of 
antibodies for other candidates. The list includes well known to unknown Golgi 
proteins. Our list also includes less well-characterized proteins containing structural 
domains that might be important for the Golgi biogenesis process. The list includes 
peripheral Golgi proteins containing trans-membrane and integral membrane domains 
(GMAP210, TMEM165, TMCO3, GOLIM4, GOLM1, GOLGB1, SYNGR2, TMED10), 
coiled coil domains (GM130, CCDC146, AKAP9, SNAPIN), Golgins and Golgi 
structural proteins (GM130, GRASP65, GRASP55, TMF1, GOLGA5, BICD2, USO1, 
GCC1, COG8). I also included uncharacterized proteins in the context of Golgi 
(TMEM165, CCDC146, TMCO3, DENN4DB, PLEKHA3), few known and unknown 
enzymes localised to the Golgi (B4GalT, GalNT2, MANEA, GAK, DYRK4). I performed 
an Immuno-staining with the antibodies for all these proteins and confirmed their 
exclusive Golgi localisation.  
Golgi proteins have been classified into different categories based on their structure and 
function. In particular, previous studies have shown that a number of proteins are 
detergent insoluble and remain associated to the Golgi upon detergent treatment. 
Hence, these proteins were suggested to form a scaffold or Golgi matrix (Cluett and 
Brown 1992; Franke et al. 1972; Slusarewicz et al. 1994; Turner and Whaley 1965). 
Several studies over the years have attributed to the structural role of many of these 
proteins. Interestingly, the same proteins were found to be accumulated in cytoplasmic 
punctate structures upon treatment with Brefeldin A (BFA) (Xiang and Wang 2011). 
Along with Golgi matrix proteins, the Trans-Golgi Network (TGN) associated proteins 
were also remnants of the Golgi upon BFA treatment. The Golgi matrix proteins were 
localised as punctate structures in the cytoplasm and TGN associated proteins were 
localised at the TGN while Golgi enzymes were completely redistributed in the ER 
(Klausner et al. 1992; Wei and Seemann 2010).  
The Golgi remnants are definitely part of the Golgi (unlike cargo proteins), and might 
play an important role in Golgi biogenesis. So our working hypothesis is that the 
remnants of Golgi upon BFA treatment might be important for the formation of a 
functional Golgi. Hence, to identify the proteins showing similar localisations to Golgi 
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matrix and TGN, I performed BFA treatment and classified the proteins into three 
different groups. To achieve this, I treated the cells with BFA for 30 min to disassemble 
the Golgi and looked at the localisations of the selected proteins. The Table 3.1 below 
shows the classification of Golgi proteins based on their localisation upon BFA 
treatment.  
Class I Class II Class III 
GMAP210 TMCO3 TMF1 
GRASP65 GOLGA5 Giantin 
GRASP55 GOLIM4 GOLM1 
TMEM165 B4GalT1 MANEA 
GM130 GalNT2 CCDC146 
USO1 BICD2 AKAP9 
COG8 GCC1 SYNGR2 
RASGEF1A BET1L ACBD3 
 DENND4B GAK 
 SNAPIN PDE4DIP 
 PLEKHA3  
 DYRK4  
 TMED10  
Table 3.1 Classification of Golgi proteins upon BFA treatment 
The selected Golgi proteins were classified into different groups based on their behaviour upon BFA 
treatment. 
 
The proteins behaving like Golgi matrix that were re-distributed in cytoplasm as clear 
punctate structures upon BFA treatment were grouped as Class I (Figure 11). The 
proteins that were exclusively or mostly localised in the ER like structures were 
grouped into Class II (Figure 12). Interestingly, I also identified few proteins showing a 
centrosome-like localisation upon BFA treatment (Figure 13). The proteins that were 
localised at the TGN or at centrosome like structures were grouped into Class III 
(Figure 13). Proteins CCDC146, GOLM1, GAK and MANEA showed a centrosome-like 
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localisation upon BFA treatment. The remaining proteins in this group showed either 
TGN or centrosome-like localisations using different fixation methods. 
According to our hypothesis, the roles of Class I and Class III proteins were further 
investigated using laser nanosurgery and RNAi. 
3.1.2 A combinatory approach: RNAi and laser nanosurgery 
I used a combinatory approach of RNAi with laser nanosurgery to achieve an acute 
depletion of Golgi proteins of interest. Laser nanosurgery is used to deplete the Golgi 
and all its associated proteins from the cell and RNAi is performed to inhibit the re-
synthesis of the protein of interest. It has been shown by our lab that the Golgi can be 
synthesized de novo upon its depletion by laser nanosurgery (Tängemo et al. 2011). 
Hence the combination of these two approaches allows us to achieve an acute depletion 
of the protein of interest and follow the Golgi biogenesis process in its absence. We 
hypothesize that the acute depletion of key regulators of Golgi biogenesis may result in 
changes in kinetics of the process or in ultra structure of the Golgi. Hence, to identify 
the effect of specific protein depletion, the Golgi biogenesis process was followed by 
time-lapse imaging and the final Golgi structure was observed using Correlative Light 
and Electron Microscopy (CLEM).  
To achieve this, the first step is to treat cells with siRNA for specific protein and deplete 
the Golgi from the cell using laser nanosurgery. In order to deplete Golgi from cells, 
they need to be seeded on coverslips coated with fibronectin lines. This allows the cells 
to stretch and move along lines, resulting in displacement of Golgi from the nucleus 
(Tängemo et al. 2011). The cells were then treated with siRNA targeting the specific 
genes of interest and subjected to laser nanosurgery to deplete Golgi.  
To be able to find back the same cells for time-lapse imaging, we inscribe a pattern 
inside glass coverslip around the cell of interest using a 355 nm UV laser (see Methods 
section). The inscription is performed several microns below the sample (inside the 
glass) to ensure that it doesn’t affect the cells.  
At the end of time-lapse imaging the cells need to be processed for EM. This involves a 
series a steps using various chemicals and finally embedding the cells into a resin. The 
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orientation of the coverslip and the approximate position of the cells can be very easily 
lost during this process. Also the inscribed pattern will not be visible after flat 
embedding of the sample for EM, as it was inscribed inside the glass coverslip and not 
on the surface. And at the end of this process it will be very tedious and almost 
impossible to find back the same cell unless we have markings on the surface of the 
coverslip to do so. Hence, to find back the cell at electron microscopic level, a protocol 
was developed and optimised by our lab for Correlative Light and Electron Microscopy 
(CLEM) (see 7.3.8). To describe the method briefly, after fixation of cells for EM, their 
position was traced back using inscribed pattern inside the coverslip and the time-lapse 
imaging data. High-energy UV laser pulses were used to remove or etch the surface of 
the coverslip on both sides of the cell of interest. These etched marks were then used for 
locating the cells in the resin or epon and were further processed to obtain serial 
sections of the entire cell. Thus CLEM was used to observe the ultra structure of Golgi 
upon depletion of protein candidates, during or after Golgi biogenesis. 
3.2 Validating the depletion of candidate proteins upon RNAi and 
laser nanosurgery 
To validate the acute depletion of the candidate proteins, the amount of protein in the 
Golgi depleted cells was compared to the neighbouring control cells after the Golgi 
biogenesis. It should be noted that the neighbouring control cells in this case were also 
treated with siRNA simultaneously as the Golgi depleted cells. Hence the amount of 
protein in the control cells will also be reduced, by the end of the experiments (typically 
20-22 hr after nanosurgery).  
As mentioned in 3.1.1 I chose the proteins from Class I and Class III to perform laser 
nanosurgery experiments in combination with RNAi. The BSC1-GalT GFP cell lines 
were optimized in the lab for laser nanosurgery experiments. As their genome was not 
fully sequenced, I designed 2 siRNAs per protein for all the proteins under view, based 
on human gene sequences. Among the 17 proteins tested 7 (GM130, GRASP55, 
GRASP65, GMAP210, TMEM165, TMF1 and GOLGB1) of them showed a clear 
knockdown by IF (data not shown). So I started the laser nanosurgery experiments with 
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these 7 candidate proteins. Proteins from the Class I (GRASP55, GRASP65, GMAP210 
and TMEM165) and Class III (TMF1 and GOLGB1) were depleted individually. Cells 
were treated with the siRNA to inhibit the synthesis of new protein and the Golgi was 
depleted. 
The cells were fixed and labelled for the depleted proteins 20-22 hr after the Golgi 
biogenesis to validate their depletion. The IF images showed an acute depletion of the 
candidate proteins in Golgi depleted cells compared to the neighbouring control cells in 
which the Golgi was not depleted (Figure 14). It must be noted that the amount of 
protein in the neighbouring control cells will also be reduced at this stage due to siRNA 
treatment. 
All the knockdowns showed an acute depletion of the protein when compared with 
their neighbouring control cells after Golgi biogenesis. The double knockdown of 
GRASP55 and 65 also showed an acute depletion of the two proteins (Figure 14). 
Despite of the depletion, the Golgi or a Golgi like structure was reformed in the 
karyoplast after the Golgi biogenesis in all the cases (Figure 14).  
3.3 Ultrastructure of the Golgi after Golgi biogenesis 
Despite of the successful reformation of the Golgi or a Golgi like structure, as judged by 
light microscopy, there might be perturbations in the Golgi structure after Golgi 
biogenesis upon depletion of the candidate proteins. To check whether the ultra 
structure of the Golgi is not perturbed and the Golgi is properly stacked, I looked at the 
ultra structure using Correlative Light and Electron Microscopy (CLEM).  
I used CLEM as mentioned earlier to find back the cells by etching the glass coverslip 
around the cells of interest, post fixation. The cells were fixed upon 20-22 hr after laser 
nanosurgery and subjected to chemical fixation for EM.  
The Golgi ultra structure of all the control cells treated with Neg9 siRNA upon laser 
nanosurgery and Golgi biogenesis showed a clearly stacked Golgi structure (Figure 15). 
However, most of them represented Golgi mini-stacks and not a clear Golgi ribbon as 
observed in case of untreated cells. The depletion of different individual proteins also 
showed a similar Golgi morphology either with stacked cisternae or Golgi ribbon 
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(Figure 15). Interestingly, the depletion of TMEM165 showed an accumulation of lipid 
droplet like structures after the Golgi biogenesis in 3 out of 5 cells imaged (Figure 16). 
The reasons for this accumulation were not further investigated, as it didn’t affect the 
Golgi biogenesis and stacking. The depletion of individual proteins did not show any 
evident changes in the Golgi morphology. Hence, I performed double depletions of 
candidate proteins to see if this has an effect on the Golgi ultrastructure. 
 A stacked Golgi was formed in all the cases including the double depletion of 
GRASP55 and 65 (Figure 15). But the double depletion of GRASP55 and 65 showed 
swollen cisternae (Figure 15). To quantify this effect the maximum luminal width of the 
Golgi cisternae was quantified in 6 control cells and 5 cells depleted for GRASP55 and 
65 using ImageJ. There was a 3.5 fold increase in the luminal width of the cisternae in 
GRASP double depletion compared to the control cells (Table 3.2).  
3.4 Time-lapse analysis of Golgi biogenesis 
3.4.1 Kinetics of Golgi biogenesis 
To quantify and compare the kinetics of the Golgi biogenesis upon depletion of protein 
candidates systematically, we used Cell Profiler and MatLab (see Methods section). Cell 
Profiler was used to segment and measure the fluorescence intensities (FIs) of the post-
ER structures or Golgi precursors throughout the time-lapse movie for each cell. Firstly, 
to segment the post-ER structures produced during Golgi biogenesis, the Golgi 
depleted cell of interest must be identified throughout the time-lapse movie. This was 
done manually by drawing a mask around the cell of interest (cell mask) through the 
entire time-lapse movie (Figure 17). As the background intensity varied between 
different time-lapse movies, a background subtraction was performed for individual 
time-lapse movies. This was done by drawing a background mask (in the area without 
any cells), through the entire time-lapse movie.  
Dynamic background subtraction per object was used as a thresholding method to 
segment the post-ER structures for the individual frames in the time-lapse movie 
(Figure 17). The total integrated FI (TIFI) of the segmented post-ER structures was 
measured. The segmentation results were compared to the time-lapse movies as a 
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quality control to ensure proper analysis. To compare the data between different cells 
and conditions, the TIFI of the Golgi precursors was normalised to its maximum value 
in each time-lapse movie. Then, the normalised TIFIs of the Golgi precursors were 
plotted with respect to time (time-lapse curve) (Figure 18). The quantitative analysis of 
time-lapse curves from several cells showed three distinct phases in the Golgi 
biogenesis (Figure 18) as also seen before (Ronchi et al. 2014).  
Upon comparing the time-lapse movies with their corresponding time-lapse curves, I 
observed that different phases of Golgi biogenesis correspond to different slopes of the 
plot over time. Changes in the TIFI slopes correspond to the changes of its time 
derivative values. Hence, to approximate the numerical derivative of these noisy time-
lapse curves I used total-variation regularisation algorithm (Chartrand 2011) 
implemented in MatLab, that eliminates the impact of stochastic noise on calculated 
derivatives. Processing quantified time-lapse TIFIs of Golgi precursors from individual 
cells with this algorithm resulted in derivative functions that exhibit sharp jumps at 
time points where original time-lapse curves change their growth rates (Figure 18b). 
First switching point (T1) typically corresponded to the switch from low (lag phase 1) to 
high (phase 2) derivative values (Figure 18a). At the second switching point (T2) 
derivatives became smaller, that corresponded to the switch from fast growing phase 2 
to saturation at phase 3 (Figure 18a). To identify these special switching time points (T1 
and T2) from the time-lapse curves we used edge detection analysis for estimated 
derivative functions (Canny 1986). The duration of phase 1 is calculated from T1 and 
the duration of phase 2 is calculated as the difference between T2 and T1. To check how 
well selected numerical differentiation procedure approximates growth of quantified 
intensity curves, I performed integration of calculated derivative functions and plotted 
integrated curves over original data (thick blue line in Figure 18a). In a very few cases 
the GFP signal was very weak and data was very noisy and hence the switching points 
T1 and T2 could not be properly identified, hence this data was not considered. A few 
examples of time-lapse curves obtained from control cells and GRASP65 & 55 double 
depleted cells are shown in Figure 19. 
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The duration of phase 1 and phase 2 was acquired from 10 cells per condition with 
different protein depletions. The results of the analysis did not show any significant 
delay in phase 1 of Golgi biogenesis upon depletion of individual Golgi proteins, 
compared to the control cells (Figure 21). However, there was an acceleration of 2.6 hr 
(mean value) in the duration of phase 1, upon single depletion of GMAP210 (p value = 
0.036). The double depletions of GRASP65 & 55 (p value = 0.0046) and GRASP65 & 
Giantin (p value = 0.005) resulted in 5.45 hr and 4.38 hr (mean values) delay in phase 1 
of Golgi biogenesis, respectively (Figure 21). There was no significant delay or 
acceleration in phase 2 upon depletion of the candidate proteins (Figure 22).  
3.5 Ultra structure of Golgi precursors in GRASP55/65 depleted 
cells 
Next, I wanted to look whether there is any difference in the intermediate structures 
during Golgi biogenesis upon double depletion of GRASP65 & 55 compared to control 
cells. So I performed CLEM during the initial stages of Golgi biogenesis, where I 
observed a delay in the kinetics upon GRASP double depletion. To do this I fixed the 
cells when I started to see the appearance of many individual Golgi precursors, which 
marks the transition between phase 1 and phase 2. I obtained data from a total of 4 cells, 
2 from double depletion (GRASP65 & 55) and 2 from control in their transition from 
phase 1 to 2. I observed that the control cells showed clear Golgi intermediates which 
were membrane bound compact and convoluted structures as reported earlier (Ronchi 
et al. 2014). I could not observe these structures in the GRASP55/65 double depleted 
cells both in transition from phase 1 to 2 (Figure 20) and 2 to 3. In GRASP55/65 double 
depleted cells, I only observed an accumulation of post ER material and some 
membrane bound cisternae like structures instead of clear intermediates (Figure 20). 
This suggests the delay in their formation or inability to form these intermediate 
structures that are necessary for maturation of Golgi precursors into a proper Golgi 
stack. These results also support the role of GRASP65 and 55 in earlier phases of Golgi 
biogenesis, which can be the reason for unflat cisternae in the Golgi ultrastructure at the 
end of Golgi biogenesis (Figure 15).  
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3.6 VSVG assay to check the efficiency of the cargo transport 
from ER to Golgi 
To test if the delay in the Golgi biogenesis upon knockdown of GRASP55 and GRASP65 
could be due to delay in the ER export, I performed a quantitative ER to Golgi VSVG 
transport assay. This assay is a well-established method in our lab that uses the 
temperature sensitive viral membrane protein tsO45G to study the efficiency of cargo 
transport from the ER. At non-permissive temperature 39.5 °C tsO45G accumulates in 
the ER and at 31.5 °C, it is transported along the Golgi to the plasma membrane.  
The BSC1-GalT cells were transfected with either control siRNA or GRASP65 and 
GRASP55 siRNA for 48 hrs. The cells are then infected with an adenovirus expressing 
YFP-tagged ts045G for 1 hr at 37 °C and then upon washing and removal of the virus 
they are transferred to 39.5 °C and incubated for 16-18 hr.  
 To study the efficiency of VSVG cargo export from ER to Golgi, it is necessary to 
identify a time-point where a moderate amount of protein reaches the Golgi, not 
completely saturating it nor allowing it to reach plasma membrane. To identify this 
time point, we performed a time-course and looked at the localisation of the protein 
after its release from the ER in BSC1-GalT cells (Figure 23). Based on these results, I 
chose 20 min time point for the experiments, as most of the protein localised to the 
Golgi with a small fraction in the ER and none at the plasma membrane. I performed 
the VSVG assay in control cells (Neg9) and in cells treated with GRASP65 and 55 
siRNA. In order to segment and measure the amount of protein in the Golgi channel, 
the cells labelled for Golgi marker protein (GM130) after fixation. The integrated FI of 
the VSVG in the total cell and the Golgi was measured (using the Golgi mask) were 
measured. The ratio of integrated FI of the Golgi to integrated FI of the total cell were 
normalised to the zero time point (t0) of the respective depletions. The results are 
plotted as a box plot and each point represents the ratio of an individual cell and dot in 
the centre of the boxplot represents the mean value (Figure 24). The results of the 
experiment show that there is no significant delay in the transport of the cargo from ER 
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to Golgi in GRASP55/65 double knockdown cells compared to control cells (Figure 24). 
These results suggest that the ER to Golgi traffic is not affected by double depletion of 
GRASP65 and 55. So the delay in the Golgi biogenesis, as described above (3.4.1), might 
be due to the improper tethering and stabilization of the Golgi precursors that occur 
during the phase 1.  
3.7 Duration of phase 1 in mitotic cells upon double knockdown 
of GRASPs 
To check the effect of double depletion of GRASPs under physiological conditions, we 
followed the Golgi biogenesis in cells undergoing mitosis. To do this, I performed time-
lapse imaging of mitotic cells treated for 72 hr with either control siRNA or siRNAs for 
GRASP55/65 (Figure 25). To identify the mitotic cells for imaging HeLa cells stably 
expressing H2B-mCherry (DNA) and GalNacT2-GFP (Golgi) were used and adaptive 
feedback microscopy was used to automatically pick mitotic cells in pro-metaphase (see 
7.3.7).  
The microscope was set up to acquire low-resolution pre-scan images (1X zoom), which 
are analysed online using the Cell cognition software package. The software uses a 
classifier to identify mitotic cells that has previously been trained by a training image 
set. Once a pro-metaphase cell is identified the software acquires high-resolution 
images (4X zoom) of H2B-mCherry and GalNacT2-GFP for an hour by taking z-stacks 
covering the entire cell, every 2.5 min.  
In cells identified during pro-metaphase, the Golgi starts to disassemble and the Golgi 
fragments disappear into the mitotic haze during metaphase. At later time-points 
during mitosis (anaphase to telophase transition), the Golgi precursors reappear to form 
an intact Golgi in the daughter cells (Figure 25). To analyse the kinetics of Golgi re-
appearance, Golgi structures were segmented throughout the time-lapse series by cell 
profiler and their integrated intensities plotted versus time. The time-lapse data showed 
similar behaviour to de novo Golgi biogenesis upon laser nanosurgery as shown earlier 
(Figure 26). The duration of phase 1 is calculated as the time between the disappearance 
of the Golgi fragments during metaphase and their re-appearance during the transition 
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between anaphase and telophase. As the Golgi biogenesis in mitotic cells occurs in less 
than an hour, even at 2.5 min resolution time-lapse movies had much less number of 
frames compared to nanosurgery experiments and the data was less noisy (Figure 26). 
So I only used edge detection analysis directly on the estimated normalised TIFIs of 
individual cells to identify the switching points T1 and T2, in this case identifying the 
disappearance (as a sudden drop in normalised TIFI) and re-appearance (as a sharp 
increase in normalised TIFI of Golgi precursors) of the Golgi complex (Figure 26). The 
duration of phase 1 was calculated as the difference between T2 and T1.  
The phase 2 in mitotic cells is very short (only a few minutes), as all the Golgi 
precursors start to appear almost at once, fuse and give rise to a complete Golgi in 
daughter cells and this can be seen as a steep increase in normalised TIFI in Figure 26. 
The time scale of the whole process is very short (~ 1 hr) as expected. Data was obtained 
from 15 cells per condition and the normalised FITI of the Golgi precursors was plotted 
with respect to time and duration of phase 1 was extracted (Figure 26).  
The average time taken for the mitosis (from pro-metaphase till the end of telophase) in 
the control cells was 49.5±2.1 min and in GRASP 65 & 55 knockdown was 46.6±2.6 min. 
This suggests that knockdown of GRASPs doesn’t effect the duration of mitosis 
significantly. In the high resolution imaged fields containing 5-10 cells per field, there 
were 1-2 cells undergoing mitosis every hour. So the average percentage of mitotic cells 
found every hour in the high resolution imaged field in control cells was 20.39±3.12% 
and in GRASP double knockdown was 23.6±4.4%.  
This shows that the GRASP double depletion also didn’t affect the frequency of mitosis 
or number of cells going into mitosis. These results suggest that GRASP65 & 55 are not 
crucial for the cells to enter mitosis. The average duration of phase 1 in control 
condition was 37.3±1.7 min and for GRASP double knockdown was 37.5±2.85 min. So 
there was also no significant difference of time taken for phase 1 between the control 
and the GRASP65 & 55 double knockdown (Figure 27).  
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Figure 10 Project outline and experimental setup 
The upper panel of the schematic shows outline of the project. This involves selection of Golgi proteins 
from Human Protein atlas project, shortlisting the candidate proteins, RNAi and laser nanosurgery 
experiments to deplete candidate proteins followed by time-lapse imaging and CLEM to identify their 
role in Golgi biogenesis. The lower panel of the schematic shows the experimental setup in detail. The 
cells seeded on fibronectin lines (allow them to stretch and move giving rise to displacement of the Golgi) 
are treated with siRNA for specific proteins for 4 hr. Then they are subjected to laser nanosurgery to 
deplete the Golgi from the cell. The karyoplast is followed by time-lapse imaging for 20-22 hr and the 
final Golgi structure is obtained using CLEM.  
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Figure 11 Classification of Golgi proteins upon BFA treatment - Class I 
Immuno-staining of the candidate proteins (GM130, GRASP65 and TMEM165) without BFA treatment 
(left) and with 30 min of BFA treatment (right). Upon BFA treatment the proteins are localised to 
punctate structures, some of which are indicated by arrowheads. All the proteins with similar localisation 
were grouped into Class I. Scale bars: 10 µm 
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Figure 12 Classification of Golgi proteins upon BFA treatment - Class II 
Immuno-staining of the candidate proteins with their respective antibodies (GalT, TMCO3 and 
PLEKHA3) without BFA treatment (left) and with 30 min of BFA treatment (right). Upon BFA treatment 
the proteins GalT and TMCO3 are localised to ER like structures. PLEKHA3 is localised mostly to the ER 
like structures with additional punctate structures. The proteins with similar localisations were grouped 
into Class II. Scale bars: 10 µm 
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Figure 13 Classification of Golgi proteins upon BFA treatment - Class III 
Immuno-staining of the candidate proteins (TGN46, CCDC146 and SYNGR2) with (30 min) (right) and 
without (left) BFA treatment. Upon BFA treatment the proteins TGN46 and SYNGR2 are localised to 
trans-Golgi like structures represented by arrowheads. CCDC146 is localised to centrosome like 
structures indicated by arrowheads. The proteins with either localised to trans-Golgi network or 
centrosome like structures were grouped into Class III. Scale bars: 10 µm. 
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Figure 14 Validation of candidate protein depletions upon RNAi and laser nanosurgery 
BSC1 GalT-GFP cells expressing GalT-GFP were treated with single siRNA (A) and two siRNAs (B) for 
specific protein candidates (labelled in red) for 4 hr and subjected to laser nanosurgery to deplete the 
Golgi. The karyoplasts were followed using time-lapse imaging and fixed with PFA upon 20-22 hr after 
laser nanosurgery. The cells are then immuno-labelled for specific proteins of the respective knockdown. 
Cells marked with arrowheads are the Golgi depleted cells. Scale bars: 10 µm. 
Results 
 57 
 
Figure 15 CLEM images of de novo Golgi upon depletion of candidate proteins 
The BSC1 GalT-GFP cells were treated with control siRNA, Neg9 or GOLGB1 or GRASP65 or GRASP55 
or TMF1 or TMEM165 or GRASP65 and GRASP55 siRNA and were subjected to laser nanosurgery to 
Results 
 58 
deplete Golgi. The Golgi biogenesis was followed by a time-lapse microscopy and the cells were fixed 
after 20-22 hr and processed for CLEM. The EM images show a de novo Golgi, upon single depletion of 
candidate proteins (GOLGB1, GRASP55 and GRASP65, TMF1, TMEM165) and double depletion of 
GRASP55 and GRASP65. The images show Golgi with stacked cisternae. Scale bar: 500nm, G: Golgi. 
 
 
siRNA Average maximum luminal width 
per cisterna (nm) 
Average number of stacks per 
cell 
Neg9 (control) 26.48 (75) 3.66 
GRASP65+55 83.53 (98) 5.2 
 
Table 3.2 Quantification of maximum luminal width of Golgi cisternae and number of stacks upon double 
depletion of GRASPs 
The BSC1 GalT-GFP cells were treated with control Neg9 siRNA or GRASP65 and GRASP55 siRNA and 
were subjected to laser nanosurgery to deplete Golgi. The Golgi biogenesis was followed by a time-lapse 
microscopy for 20-22 hr and the cells were fixed and processed for CLEM. The quantification of EM 
images from control cells (n=6) and GRASP double depletion (n=5) showing the average maximum 
luminal width per cisterna and average number of stacks per cell. The numbers in brackets indicate the 
number of cisterna quantified. 
 
 
Figure 16 Lipid droplets in TMEM165 depleted cells 
BSC1 GalT-GFP cells were treated with control Neg9 siRNA or TMEM165 siRNA and were subjected to 
laser nanosurgery to deplete Golgi. The Golgi biogenesis was followed by a time-lapse microscopy for 
and the cells were fixed and processed for CLEM. The EM images from three cells show an accumulation 
of lipid droplets after 20-22 hr of Golgi biogenesis. Arrowheads indicate a few lipid droplets. Scale bar: 1 
µm. 
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Figure 17 Phases in Golgi biogenesis 
Upper panel shows the karyoplast of a control cell at different time points that was followed by time-
lapse imaging. The arrowheads in the upper panel indicate the Golgi depleted cell after laser 
nanosurgery. The lower panel shows the corresponding cell mask to segment the cell and post-ER 
structures segmented by using Cell profiler pipeline. The images represent cells at different phases of the 
Golgi biogenesis. The images show segmented post-ER structures (f) during the transition from phase 1 
to phase 2, their clustering during phase 2 (g) and merging of these clusters together (h) during the 
transition from phase 2 to phase 3.  
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Figure 18 Time-lapse curve of Golgi biogenesis 
The upper panel (a) shows normalized TIFI of Golgi precursors plotted against time in a control cell. The 
lower panel (b) shows the numerical derivative calculated using total-variation regularisation algorithm. 
T1 and T2 are the switching points identified from the derivative by using edge detection analysis. T1 
represents the duration of phase 1 and T2-T1 represents the duration of phase 2 respectively. The thick 
blue line in the time-lapse curve represents the integration of the calculated derivative functions. 
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Figure 19 Time-lapse curves of GRASP double depletion and control  
BSC1 GalT-GFP cells were treated with control Neg9 siRNA or GRASP65 and GRASP55 siRNA and were 
subjected to laser nanosurgery to deplete Golgi. The Golgi biogenesis was followed by a time-lapse 
microscopy and Golgi precursors were segmented using Cell profiler and the TIFI of the structures was 
extracted. The plots show normalized TIFI of Golgi precursors plotted against time for individual cells 
(A, B, C and D). Edge detection analysis was used to identify the switching points from calculated 
numerical derivative. Plots A, B and C are obtained from time-lapse movies of control cells and Plots D 
and E from GRASP65 and 55 double depleted cells. The thick blue lines in the time-lapse curve represent 
the integration of the calculated derivative functions. 
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Figure 20 CLEM of Golgi precursors upon double depletion of GRASP65 & 55 compared to control 
The BSC1 GalT-GFP cells were treated with control siRNA (Neg9) or GRASP65 & 55 siRNA and were 
subjected to laser nanosurgery to deplete Golgi. The Golgi biogenesis was followed by a time-lapse 
microscopy and the cells were fixed immediately when Golgi precursors (phase 1->2) were observed and 
processed for CLEM. The EM images show Golgi precursors produced during Golgi biogenesis in both 
conditions. The images show membrane bound compact and convoluted structures (arrowheads) in 
control condition together with accumulation of small vesicles and post-ER material (region enclosed 
with dotted lines). The cells depleted for GRASPs show membrane bound structures (different from 
control) (arrowheads) and accumulation of post-ER material (region enclosed with dotted lines). Scale 
bar: 1µm. 
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Figure 21 Duration of phase 1 in Golgi biogenesis upon depletion of Golgi proteins 
The duration of phase 1 extracted from the time lapse data upon depletion of different proteins is plotted 
as a box plot. Each point in the plot represents a cell (n=10). The mean value of each condition is 
represented as a black dot and line represents the median. The p value for depletion of GMAP210 
compared to Neg9 is 0.036. The p values for the double depletions of GRASP65 and 55, GRASP65 and 
Giantin are 0.0046 and 0.005, respectively. 
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Figure 22 Duration of phase 2 in Golgi biogenesis upon depletion of Golgi proteins 
The duration of phase 2 extracted from the time lapse data upon depletion of different proteins is plotted 
as a box plot. Each point in the plot represents a cell (n=10). The median is represented as a line and the 
mean value is represented as a black dot for each condition. 
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Figure 23 Time course of temperature sensitive VSVG (VSV-G ts045) upon its release from the ER 
BSC1 cells infected with adenovirus to express a YFP-tagged temperature-sensitive vesicular stomatitis 
virus G protein (VSV ts045-G ) for 1 hr at 37 °C and then upon washing and removal of the virus they are 
transferred to 39.5 °C and incubated for 16-18 hr. The cells were then shifted to 31.5 °C to release the 
protein and fixed at different time-points. Images show the change of localisation of the protein from the 
ER to the Golgi. Scale bar: 10 µm. 
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Figure 24 Comparison of ER to Golgi transport by VSVG assay in control and GRASP double knockdown 
BSC1 cells were transfected with control and GRASP65 & 55 siRNAs for 48 hr and then infected with 
adenovirus to express a YFP-tagged ts045 VSV-G protein for 1 hr at 37 °C. They were then transferred to 
39.5 °C and incubated for 16-18 hr. The cells were fixed after 0 min and 20 min upon the release of the 
cargo (YFP- tagged VSV-G ts045) from the ER by a temperature shift to 31.5 °C. The boxplots (A,B and C) 
show the results of three individual experiments of VSVG assay in control cells (Neg9) and GRASP65 and 
55 double depleted cells (GRKD). The Y-axis represents the ratio of integrated FI of the Golgi to 
integrated FI of the total cell, normalised to the zero time point (t0) of the respective depletions. Each 
point represents the ratio of an individual cell and dot in the centre of the boxplot indicates the mean 
value. The boxplot D represents the data from all the three experiments.  
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Figure 25 Golgi biogenesis during mitosis in GRASP 65 & 55 depleted cells 
HeLa Kyoto cells expressing GalNacT2-GFP and H2B-mCherry were treated with control siRNA Neg9 
and GRASP 65 & 55 siRNA. The images show the Golgi marker GalNacT2-GFP. The upper panel shows 
an example of a cell undergoing mitosis under control conditions (Neg9). The lower panel shows an 
example of GRASP 65 & 55 double knockdown cell during mitosis. The time indicated is in minutes 
during the time-lapse after identifying the mitotic cells. Scale bar: 10 µm. 
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Figure 26 Time-lapse curve showing duration of phase 1 in mitotic cells 
HeLa Kyoto cells expressing GalNacT2-GFP and H2B-mCherry were treated with control siRNA. The 
mitotic cells were identified during the pro-metaphase and were imaged by a confocal microscope for 1hr 
with a 2.5 min time resolution throughout the mitosis. The upper panel (a) shows the H2B-mCherry 
(nucleus) and the middle panel (b) shows GalNacT2-GFP (Golgi). The Golgi precursors were segmented 
from the Golgi channel using Cell profiler from the time-lapse data and the TIFI of the structures was 
extracted. The normalized TIFI of Golgi precursors were plotted against time (c). Edge detection analysis 
was used to identify the switching points (T1 and T2) based on the normalised TIFI. Phase 1 was 
calculated as the difference between T2 and T1. The upper panels (a, b) show the time-lapse images of the 
cell corresponding to the plot in the lower panel (c). Scale bar: 10 µm and t: time (min). 
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Figure 27 Duration of phase 1 in mitotic cells upon depletion of GRASPs 
The duration of phase 1(min) extracted from the time-lapse data from control cells (Neg9) and upon 
depletion of GRASP65+55 is plotted. Each point in the plot represents a cell (n=15). The mean value of 
each condition is represented as a black dot and the line represents the median. 
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4 Discussion 
Although, the Golgi complex was first identified more than hundred years ago, the 
knowledge about the precise function of the molecules that localise to it is still lacking. 
Despite of a number of Golgi proteins being known, their role in the Golgi biogenesis 
process is still not very clear due to large amounts of conflicting data. The goal of my 
PhD work was to get more insights about the key molecular regulators of this event and 
their role in the process, by taking advantage of the laser nanosurgery approach 
previously developed in our laboratory.  
I used Golgi localisation as a first criterion to identify putative candidate proteins that 
might be involved in Golgi biogenesis process. First, I screened the Human Protein 
Atlas (HPA) database (Berglund et al. 2008) and selected a list of 31 proteins exclusively 
localised to the Golgi and with structural domains that might be important in Golgi 
biogenesis. Localisation of these proteins after treatment of cells with Brefeldin A 
allowed me to cluster these proteins into three classes: (i) Golgi matrix-like proteins 
which accumulate as distinct structures throughout the cytoplasm (ii) Golgi enzyme-
like proteins, which relocate to the ER and (iii) TGN/Centrosome-like proteins which 
remained concentrated in the juxta-nuclear region of the cell similar to the TGN marker 
TGN46 or localised to dot like structure similar to centrosomal marker CNAP. This 
revealed the behaviour of several new proteins (CCDC146, TMEM165, TMCO3, 
DENN4DB and PLEKHA3), some of which (TMEM165 and CCDC146) showed Golgi 
matrix-like and Centrosome-like localisations respectively and thus might be good 
candidates to represent new regulators of Golgi function.  
In an attempt to characterise the role of these selected proteins for de novo Golgi 
biogenesis, I used a combination of RNAi and laser nanosurgery techniques to achieve 
acute depletion of these proteins followed by siRNA mediated inhibition of their 
synthesis during Golgi biogenesis. I validated the acute depletion for 7 proteins and 
used the combinatory approach to identify their roles in Golgi biogenesis. These 
proteins also include known Golgins and GRASPs, which have been proposed to play 
an important role in Golgi maintenance and function.  
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Acute depletion of none of these individual proteins tested showed a significant effect 
on the kinetics of Golgi biogenesis process, despite of their efficient depletion. This 
implies that Golgi biogenesis is highly robust and can occur even under the depletion of 
individual putative candidate proteins. When double knockdowns of some protein 
combinations were performed, I identified a significant delay in the earlier stages of the 
process upon knockdown of certain combinations (GRASP65 & GRASP55, GRASP65 & 
Giantin). This suggests a possible redundancy among proteins involved in this process. 
The main events occur during the earlier stages are tethering and stabilization of post-
ER material.  
When I looked at the ultra structure of the Golgi upon acute depletion of individual 
proteins, I could not identify morphological changes in the Golgi structure with any of 
the single knockdowns tested. This also ascertains the robustness of the Golgi 
biogenesis process and being able to compensate for the loss of certain proteins. When I 
looked at the double knockdown of GRASP65 and GRASP55, cisternae in stacks 
appeared to be much thicker and not very flat compared to other protein depletions or 
control experiments. This also suggests that there is a redundancy among Golgi 
proteins and hence an effect on the ultra structure was identified only upon double 
depletion.  
There exist at least two possibilities to explain the delay in initial stages of Golgi 
biogenesis. The first one is a possible delay in the ER to Golgi transport and the second 
is a key role of these proteins in initial stages of the process. To investigate which of 
these two possibilities may be true, I performed a VSVG transport assay and the results 
of this experiment showed that, under the conditions used here in this work, there is no 
significant delay in ER to Golgi traffic upon double depletion of GRASP65 and 55. This 
implies that these two proteins play a crucial role in the initial stages of the Golgi 
biogenesis process or the VSVG assay was not sensitive enough in my experiments to 
detect the delay in the ER to Golgi transport. As the double depletion of GRASPs also 
affected the final Golgi ultra structure and previous literature studies suggested their 
role in tethering, I consider it more likely that these proteins play an important role in 
the events occurring in the initial stages of the process. To further clarify this, I looked 
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at the ultrastructure of the Golgi precursors during the initial stages of the Golgi 
biogenesis. I identified that the intermediate structures differ in the GRASP65 & 55 
double depleted cells compared to control cells. This shows that GRASPs play a 
complementary role in initial phases of Golgi biogenesis and are important in the 
formation of compact, convoluted structures which give rise to a proper stacked Golgi.  
4.1 Combinatory approach to identify the molecular regulators of 
Golgi biogenesis 
The methods and tools used to study the Golgi biogenesis previously in the literature 
have a common limitation due to their inability to remove the Golgi completely. Hence 
the laser nanosurgery technique developed in our lab is very useful tool to understand 
the key players in this process, as it allows the complete removal of Golgi and its 
associated proteins (Tängemo et al. 2011). RNAi approaches have been used to study 
various molecules to understand their role(s) in Golgi biogenesis. In such approach, 
cells are treated with siRNA to degrade the mRNA, thus resulting in blockage of 
specific protein synthesis. But degradation of existing proteins in the Golgi usually can 
take several hours to days depending on the lifetime of specific protein under view. As 
the depletion in this case is not acute, it might allow enough time for cells to activate 
alternative mechanisms to compensate for the loss of the specific protein. Hence, the 
effects observed in such studies might not always reflect direct functional significance 
of individual proteins, which may explain the numerous conflicting literature data 
existing e.g. for Golgi Matrix proteins. Hence, to overcome these limitations, I used a 
combinatory approach of RNAi and laser nanosurgery to study the role of individual 
Golgi proteins during Golgi biogenesis. It has been shown earlier that there was no sign 
of any Golgi membranes or remnants in the karyoplast after the laser nanosurgery was 
performed to deplete the Golgi (Tängemo et al. 2011). Thus acute depletion of specific 
Golgi localised proteins was shown to be achieved by combining this approach with 
RNAi, to inhibit the re-synthesis of these proteins (Tängemo et al. 2011).   
Although laser nanosurgery approach is quite advantageous, the Golgi biogenesis 
process occurring in this context might not exactly mimic physiological mitotic Golgi 
Discussion 
 
 73 
reassembly. But the molecular players involved in this process should be the same, as it 
leads to the formation of a fully functional Golgi complex. Hence I used this 
combinatory approach to identify and characterise the role of different molecular 
players in the Golgi biogenesis process, rather than characterising the process itself. 
Along with the many pros, there are also certain cons for this approach. As only a small 
percentage of cells show a Golgi displacement from the nucleus, it allows Golgi 
depletion only in these cells. As only a few cells can be studies at any time, performing 
experiments with a number of gene combinations is time-consuming.  Hence it is a very 
low throughput, technically challenging method. 
4.2 Selection and Classification of candidate proteins 
Most of the proteins that were suggested to play different key roles in maintenance of 
the Golgi so far are localised to the Golgi complex (e.g: GM130, GRASP65 and 
GRASP55). So it might be crucial for proteins to localise to the Golgi if they are involved 
in events like tethering, stacking or ribbon formation occurring during Golgi biogenesis. 
Hence our selection of candidate proteins is based on the hypothesis that proteins 
localised exclusively to the Golgi are important for biogenesis process. I took advantage 
of the HPA localisation database to identify exclusively Golgi localised proteins. As I 
only considered exclusively Golgi localised proteins, I excluded any cargo proteins 
travelling through the Golgi (also localised in other organelles) and thus may not 
necessarily play a role in the biogenesis.  
In my project I took advantage of the well-established BFA treatment of the cells as a 
way to distinguish proteins behaving like Golgi matrix, Golgi enzyme or TGN 
(Seemann et al. 2000). Interestingly, I also identified proteins localised to centrosome-
like structures upon BFA treatment. Though the significance of this centrosome-like 
localisation upon BFA treatment is not very clear, they might be proteins that link the 
Golgi complex to the centrosome thus maintaining its peri-centrosomal localisation in 
the cell. It will be very interesting to follow up on these candidate proteins to 
understand their clear function.  
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It has been several years since the concept of Golgi matrix was introduced through 
identification of detergent insoluble proteinaceous structure (Slusarewicz et al. 1994), 
several components of this matrix have been detected. These are identified as proteins 
mainly belonging to the Golgin, GRASP and coiled-coil protein families (Lupashin and 
Sztul 2005; Ramirez and Lowe 2009; Short, Haas, and Barr 2005). But the functional 
characterisation of most of these identified proteins have not been yet performed. So 
this assay is very useful to give insights into the function of already known proteins or 
reveal new protein candidates by distinguishing Golgi proteins based on their 
behaviour. Hence it has the potential for a comprehensive screen to classify all the Golgi 
localised proteins according to their behaviour like the Golgi matrix, Golgi enzyme or 
TGN.  
One caveat for this approach might be that the antibodies used, being unspecific. This 
can be overcome by testing and validating them through methods such as RNAi. I did 
this siRNA validation for the 7 candidate proteins chosen for the laser nanosurgery 
experiments and efficient protein depletions were confirmed.  
4.3 Effect of protein depletions on Golgi ultrastructure 
There was no significant change in the overall ultra structure of Golgi formed after 20-
22 hr of Golgi biogenesis (stacking, Golgi ribbon etc.,) upon acute depletion of 
individual proteins by RNAi and laser nanosurgery. This is also consistent with 
literature studies where there were only subtle changes upon siRNA knockdown of 
some of these proteins (Giantin, GRASP55 and GRASP65) whereas overall stacking, 
cisternal length etc., remained unchanged (Koreishi et al. 2013; Tang, Yuan, and 
Yanzhuang 2010; Yi Xiang and Wang 2010b). It has been shown that knockdown of 
GMAP210 results in fragmentation of the Golgi when observed under light microscopy 
and a complete disassembly of Golgi stack under electron microscopy (Sato et al. 2014). 
The Golgi ultra structure upon depletion of GMAP210 hasn’t been yet studied with my 
experimental set up but it will be addressed in the near future.  
The double depletion of GRASP55 and 65 by RNAi and laser nanosurgery resulted in 
swollen unflat cisternae in the Golgi stack (Figure 15). This is in agreement with results 
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obtained by another group, where they observed that the double knockdown of 
GRASP65 and 55 also resulted in swollen cisternae. The same results were 
demonstrated and reproduced using a different set of siRNAs for the target genes (Lee 
et al. 2014). These results imply a crucial role of GRASP65 and 55 in flattening of the 
cisternae rather than stacking itself. As the individual depletions of GRASPs didn’t 
show this effect, it implies that these proteins play complementary roles in this process. 
But these results contradict the study where it was shown that siRNA knockdown of 
GRASP55 and 65 results in complete disruption of the Golgi stack at the ultra structural 
level (Y. Xiang and Wang 2010). And hence it was proposed that GRASPs are involved 
in stacking of the Golgi cisternae and their depletion results in complete disassembly of 
the Golgi stack (Y. Xiang and Wang 2010). This discrepancy among different studies 
might be explained by the usage of different siRNAs or different sensitivities of cell 
lines. The combinatory approach used in this project is unique compared to the other 
above-mentioned studies as it achieves an acute depletion of the protein. And hence, 
the effects of the depletion can rather be direct allowing the characterisation of the role 
of the depleted proteins. Further experiments are necessary to study the Golgi ultra 
structure upon double depletion of GRASP65 & Giantin and any other possible 
combinations, which show an effect in the Golgi biogenesis process. This can help in 
identification of specific roles of proteins working in tandem based on their effects on 
the ultra structure.  
4.4 Initial stages of Golgi biogenesis – the rate limiting step 
The analysis of kinetics of Golgi biogenesis upon depletion of different individual 
proteins by RNAi and laser nanosurgery showed a significant acceleration in the initial 
phase of the process only in case of GMAP210. This suggests that GMAP210 acts as a 
negative regulator of Golgi biogenesis. GMAP210 was shown to be involved in binding 
to microtubules or anchoring microtubules to Golgi membranes (Infante et al. 1999; 
Ríos et al. 2004), so it can be speculated that its presence results in a distribution of post-
ER material throughout the cytoplasm through microtubule tracks. Whereas its absence 
might leave the material at the site of synthesis, leading to faster fusion and 
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accumulation of the material. In support of this hypothesis depolymerisation of the 
microtubule network by nocodazole resulted in an acceleration of Golgi biogenesis 
(Ronchi et al., 2014). This hypothesis needs to be further tested and validated to 
understand the role of GMAP210 in this process. Although individual depletions of 
GM130 and GRASP65 showed a slight delay in the phase 1, the effect was not 
statistically significant when a t-test was performed. This delay in the phase 1 upon 
depletion of GM130 is consistent with the previously published results (Tängemo et al. 
2011).  
Among different combinations of double depletions performed, GRASP65 & GRASP55 
and GRASP65 & Giantin showed a significant delay in the initial phase of the Golgi 
biogenesis process. This delay can be explained either by the crucial role of these 
proteins in the initial phases of Golgi biogenesis or their role in the ER to Golgi 
transport. The evidence from the VSVG transport assay upon siRNA knockdown of 
GRASP65 and 55 showed that, there was no evident delay in the ER to Golgi transport. 
Hence, this implies that GRASP65 and 55 play an important role in initial stages of the 
process. Also, this delay can be the source for the lack of cisternal flatness in the Golgi 
ultra structure. Consistent with these findings increased levels of GRASP65 and 
GRASP55 were observed in the earlier stages of Golgi biogenesis compared to other 
proteins (Giantin and AKAP9) (Ronchi et al. 2014).  
The later stages (phase 2) of Golgi biogenesis were not affected upon depletion of 
individual proteins. Also there was no significant delay or acceleration of phase 2 upon 
double depletions of selected proteins. This suggests that the critical rate-limiting step 
for Golgi biogenesis process is phase 1 rather than phase 2, at least for the proteins 
tested in this work. But whether this concept of rate-limiting step is true under 
physiological mitotic Golgi biogenesis is questionable, as the system used in this study 
is not exactly identical to the events occurring during mitosis. Hence this approach is 
highly useful to study the molecular regulators of the process rather than the process 
itself.  
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4.5 Ultrastructure of Golgi precursors during Golgi biogenesis 
To test our hypothesis, whether the delay in initial phases of Golgi biogenesis upon 
GRASP double knockdown can be the source for the lack of cisternal flatness in the 
Golgi ultra structure, I looked at the ultra structure of Golgi precursors. The CLEM data 
from GRASP double depleted cells showed a lack of typical compact and convoluted 
structures observed in control cells during the transition from phase 1 to 2 or 2 to 3.  
Though the accumulation of the post-ER material at the ER exit sites occurs in both 
cases, the formation of these Golgi intermediates (or precursors) is delayed or impaired 
in GRASP double depleted cells. As there were structures ranging from accumulation of 
material at ER exit sites to accumulation of vesicular structures during the transition, I 
could not find a robust way to quantify these data. Overall, there is an apparent 
difference in the Golgi intermediates upon double depletion of these proteins compared 
to the control condition, supporting our hypothesis. The inability of these cells to form 
the proper Golgi precursors can be the reason for cisternal swelling at the end of the 
Golgi biogenesis process. It also explains the delay in the initial phases of the biogenesis 
process. 
4.6 Golgi biogenesis in mitotic cells 
To understand if this delay in the initial phase of the Golgi biogenesis can also be seen 
in physiologically relevant process such as mitosis, I performed time-lapse analysis of 
Golgi biogenesis in mitotic cells which were double depleted of GRASP65 & 55. 
Automated adaptive feedback microscopy, as it has been developed in our laboratory 
(Conrad et al., 2011), was used to automatically identify mitotic pro-metaphase cells 
based on their nuclear DNA morphology. There was no significant difference in the 
kinetics of appearance of Golgi precursors at the anaphase/telophase transition, which I 
defined as equivalent to the phase 1 in the laser nanosurgery experiments.  
Possible reasons for this can be that as mitosis occurs at a very fast pace, it is not easy to 
detect the subtle differences occurring during this process with the 2.5 min time 
resolution possible with the microscope system available for these experiments. In 
addition, as GRASP65 & 55 knockdown is not as acute as in case of laser nanosurgery 
Discussion 
 
 78 
experiments there might be still remnant protein molecules that are enough to 
compensate for the loss of others. Another possibility is that the effect can be 
accumulative and can only be observed when more rounds of cell division are analysed. 
Unfortunately, this is technically challenging to do, as the exposure to light for longer 
periods might stress the cells and hence it might be difficult to follow them for several 
mitotic rounds. Also, imaging mitotic cells with less time intervals is stressful for the 
cells and might lead to apoptosis.  
As I use an artificial system (depleting Golgi by laser nanosurgery) in my experiments 
the Golgi biogenesis process occurs with different kinetics compared to Golgi 
biogenesis after mitosis. This has allowed me to reveal the effects on Golgi biogenesis as 
described in this work. Whether these effects are also relevant for Golgi biogenesis after 
mitosis currently remain elusive. 
4.7 Redundancy of Golgi proteins in Golgi biogenesis 
As mentioned earlier, depletion of most of the individual proteins didn’t show any 
effect on Golgi biogenesis but some double depletion of the same proteins led to a 
significant delay in the process. This strongly shows functional redundancy among 
certain candidate proteins, where the effect could only be seen if proteins with 
concerted functions are simultaneously depleted. This redundancy is also supported 
from previous literature studies, which showed the knockdown of combination of 
specific Golgins and GRASPs (Golgin45, GRASP65 and 55) led to complete disassembly 
of the Golgi stack. But the depletion of GM130, GRASP65 and 55 led only to a partial 
disassembly of the Golgi stack (Lee et al. 2014). This also implies that so far there has no 
single protein acting as a master regulator of this process been detected and may not 
even exist. Golgi biogenesis is a complex mechanism and it can be speculated that it 
involves partial redundancy among specific Golgi proteins making the process more 
robust. Further systematic analysis of different combinations is necessary to interpret 
specific functions of the proteins involved in this process.  
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4.8 Proposed role of GRASPs 
Based on our results and from the CLEM data in control cells and GRASP 65 & 55 
double depleted cells, I propose that these two proteins play an important role in the 
initial stages of Golgi biogenesis. In particular, they are crucial for the formation of 
Golgi intermediates that are needed for maturation of the precursors into a proper 
Golgi. The different steps in the process based on the CLEM data in the presence and 
absence of GRASPs can be depicted as outlined in Figure 28.  
 
 
Figure 28 Events occurring at ultra structural level during Golgi biogenesis in control and GRASP double 
depletion 
Events occurring during Golgi biogenesis in control cells include formation and accumulation of post-ER 
material (step 1), formation of Golgi precursors (step 2) and their maturation giving rise to Golgi complex 
(Step 3). Upon depletion of GRASPs, the formation of Golgi precursors is delayed or impaired resulting 
in unflat Golgi stack.  
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The scheme in Figure 28 shows the formation and accumulation of post-ER material in 
the initial phase of Golgi biogenesis both in control and GRASP 65 & 55 depleted cells. 
The accumulation of post-ER material occurs in later phases under both conditions. But 
the formation of Golgi intermediates does not occur in GRASP 65 & 55 depleted cells. 
This might imply either a delay in their formation or inability to form resulting in 
swollen/unflat Golgi stack in GRASP double depleted cells compared to control cells 
(Figure 15). 
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5 Outlook 
In this study I identified that GRASP 65 & 55 play a role in concert in the initial stages 
of Golgi biogenesis. And this role is important for formation and maturation of Golgi 
precursors into a proper Golgi. Further CLEM experiments on intermediate stages of 
Golgi biogenesis upon depletion of these two proteins might be necessary to fully 
understand their role. This study also shows that this combinatory approach is a very 
useful tool to validate the role of other proteins in Golgi biogenesis. But as this method 
is not high throughput, it is possible to validate only a limited number of candidate 
proteins. 
In this study, I was not able to identify the major players that might be very crucial for 
the Golgi biogenesis process, although it should be possible using this method. One 
reason for this might be that the right genes were not tested due to the limitations of 
their knockdown or the availability of antibodies for those proteins. Hence, to overcome 
this limitation laser nanosurgery approach can be combined with single cell sequencing 
methods (Bandyopadhyay et al. 2014; Lovatt et al. 2014) to analyse the transcriptome of 
the Golgi depleted cells over time in order to identify interesting new candidates 
involved in Golgi biogenesis revealed by their altered expression in comparison to 
control cells. The transcriptomics data might reveal new candidate proteins or already 
known candidates that are very important for the Golgi biogenesis process. The role of 
such few major players can be validated by their acute depletion through RNAi and 
laser nanosurgery.  
Another promising approach to identify major regulators of Golgi biogenesis is through 
scaling up the BFA assay to classify identified Golgi localised proteins at a genome 
scale. This can be expected to reveal more Golgi proteins behaving like Golgi matrix 
and playing an important role in the Golgi biogenesis process. However, 
characterisation of the identified proteins in a comprehensive manner by laser 
nanosurgery approach might be challenging. This limitation could be overcome by 
using a multi-labelling approach (Schubert et al. 2006), where several tens of proteins 
can be labelled with antibodies in a single cell. This can be used to label fixed cells for 
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multiple proteins at different time-points during the Golgi biogenesis. Hence, it would 
allow ranking of the proteins according to their order of arrival or abundance in 
different phases of Golgi biogenesis and thus narrow the selection of candidates that 
could be further validated using laser nanosurgery approach.  
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6 Materials  
6.1 Cell culture 
6.1.1 Eukaryotic cell lines 
Cell line Description Source Media 
BSC-1 African green monkey kidney 
cells 
ATCC 
(CCL-26) 
MEM 
BSC-1-GalT-GFP2 BSC-1 cell line stably expressing 
GalT-GFP2 
EMBL, 
Heidelberg 
MEM 
HeLa Kyoto Strongly adherent HeLa isolate Kyoto University, 
Japan 
DMEM 
HeLa-GalNacT2-
GFP 
HeLa cell line stably expressing 
GalNacT2-GFP 
Brian Storrie, 
Virginia Polytechnic 
Institute and State 
University, Virginia 
DMEM 
 
6.1.2 Reagents for Cell culture 
All culture media and reagents were purchased from Gibco unless indicated and FCS 
was purchased from PAA laboratories GmBH. 
Media Cat. No. 
MEM (Modified Eagle’s 
Medium) 
21090-022 
DMEM (Dulbecco’s Modified 
Eagle Medium, 1 g/L D-glucose) 
31885-023 
OptiMEM 51958 
FCS (Fetal Calf Serum) A15-101 
0.05% Trypsin-EDTA 25300-054 
Geneticin 10131 
CO2 Independent medium ME080051L1 
 
6.1.3 Cell culture and imaging media 
Media Composition Cell types 
MEM complete 
10% (v/v) FCS 
BSC-1, BSC-1-GalT-GFP2 
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1% (v/v) L-glutamine 
DMEM complete 
10% (v/v) FCS 
1% (v/v) L-glutamine 
HeLa Kyoto, HeLa-GalNacT2-
GFP 
Freezing medium 
DMEM/MEM 
20% (v/v) FCS 
10% (v/v) DMSO 
BSC-1, BSC-1-GalT-GFP2, HeLa 
Kyoto, HeLa-GalNacT2-GFP 
Imaging medium 
CO2 Independent Medium  
10% (v/v) FCS 
1% (v/v) L-glutamin 
BSC-1, BSC-1-GalT-GFP2, HeLa 
Kyoto, HeLa-GalNacT2-GFP 
Low FCS MEM Medium  
MEM 
1% (v/v) FCS 
1% (v/v) L-glutamine 
BSC-1-GalT-GFP2 for laser 
nanosurgery experiments 
 
6.1.4 Chemicals and drugs 
Chemical Source Cat.No. 
Brefeldin A Sigma-Aldrich B7651 
Dimethylsulphoxide (DMSO) Merck  102952 
Hoechst Sigma-Aldrich 33258 
Methanol Merck 106009 
Mowiol Calbiochem 475904 
Oligofectamine Invitrogen 12252-011 
Paraformaldehyde Polysciences Inc., 00380-250 
Saponin Sigma-Aldrich 47036 
Acetone Merck  1.00014 
Ethanol Merck  100983 
Adenoviral vector VSVG-t045-
YFP (JJ_2015: Dilution 1:200) 
Vector biolabs - 
 
6.1.5 Buffers and solutions 
Buffer/Solution Source and Composition 
Phosphate Buffer Saline (PBS) EMBL Media kitchen 
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137 mM NaCl 
2.7 mM KCl 
1.4 mM KH2PO4 
4.8 mM NA2HPO4/Na2CO3 
Adjusted to pH 7.4, autoclaved 
3% Paraformaldehyde (PFA) Electron Microscopy Science 16% (#15710) 
Saponin solution Sigma-Aldrich 
0.1% Saponin 
10% FCS 
PBS 
 
6.1.6 Special equipment and material/Others 
Equipment/Material Source 
Centrifuge 5804R Eppendorf 
Microcentrifuge 5417R Eppendorf 
10cm Cell culture dishes NuncTM 
0.5 ml, 1.5 ml, 2 ml tubes Eppendorf 
15 ml and 50 ml Falcon tubes BD Biosciences 
Glass bottom dishes MatTek COrporation 
Cryotubes 1.5 ml NuncTM 
4 well LabTeks NuncTM 
Incubator Binder 
Water bath GFLR 
Table centrifuge Sarstedt 
Cell freezing container Nalgene 
Cell counting chamber Superior Marienfeld 
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6.2 Microcontact printing 
6.2.1 Reagents 
Reagent Source Cat. No. 
Fibronectin (from Bovine plasma) Sigma-Aldrich F1141-1MG 
Glisseal N (Silicon-free grease) Borer Chemie - 
Sylgard 184 kit (Silicone elastomer) Dow Corning 1064291 
Compressed Nitrogen gas MESSER 50719294 
mPEG-SPA-2000/5000 Shearwater - 
 
6.2.2 Other equipment and material 
Material/Equipment Source 
Glass coverslips (~15 mM) Menzel Glaser 
Petri dishes (~35 mM) Falcon 
Plasma Prep2 Structure Probe 
Vacuum Desiccator Sybron Corporation 
 
6.3 Oligonucleotides 
All siRNAs were ordered from Life technologies unless mentioned. 
Gene 
Symbol 
siRNA 
ID  
Sense siRNA Seq. 5'->3' Antisense siRNA Seq. 5'->3' 
GORASP2 s24914 CUAUUACACCUCUUAAAGAtt UCUUUAAGAGGUGUAAUAGgt 
GORASP1 s34818 CGCUCAUCGAGUCUCAUGAtt UCAUGAGACUCGAUGAGCGta 
GORASP1 s34819 GAAUUUCUCUCUUGGACAAtt UUGUCCAAGAGAGAAAUUCcc 
Giantin s5951 GAAGCUUGAGGAACACGAAtt UUCGUGUUCCUCAAGCUUCct 
TMEM165 s31677 GCUCUCAACUAACUACAAUtt AUUGUAGUUAGUUGAGAGCga 
Neg9 s444246 UACGACCGGUCUAUCGUAGtt CUACGAUAGACCGGUCGUAtt 
TMF1 s14227 GGAGAUACCCAAACUUAGAtt UCUAAGUUUGGGUAUCUCCtt 
GOLGA2 145093 GGCUGGCAUGCAGCUUAACtt GUUAAGCUGCAUGCCAGCCtt 
GMAP210 
(Dharmac
on) 
ON-
TARGE
Tplus 
GGAGAUAGCAUCAUCAGUA 
CAAGAACAGUUGAAUGUAG 
GGACAUUACUAAAGAGUUA 
UACUGAUGAUGCUAUCUCC 
CUACAUUCAACUGUUCUUG 
UAACUCUUUAGUAAUGUCC 
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SMAR
T pool 
GGGCAAGACUGGAGAGUUA UAACUCUCCAGUCUUGCCC 
 
Custom designed siRNAs are listed in the table below. 
Gene Symbol Sense siRNA Seq. 5'->3' Antisense siRNA Seq. 5'->3' 
GORASP1 CCUGGACGUGUCAGGAAUUtt AAUUCCUGACACGUCCAGGaa 
GORASP1 CCAGGCAGAGUGACUACAUtt AUGUAGUCACUCUGCCUGGaa 
GORASP2 CUGUCGAGAAGUGAUUAUUtt AAUAAUCACUUCUCGACAGtt 
 
6.4 Immunofluorescence 
6.4.1 Primary Antibodies 
Protein Host Source Fixation Dilution 
GM130 mouse BD Biosciences PFA 1:400 
Giantin rabbit Abcam PFA 1:600 
CNAP goat Elmar Schiebel Group 
Heidelberg University 
Methanol  
TGN46 sheep Biozol PFA 1:300 
GRASP65 sheep Martin Lowe, 
University of Manchester 
PFA  
 
All the below mentioned antibodies were produced in rabbit, obtained from Emma 
Lundberg (Human Protein Atlas, SciLifeLab, Stockholm, Sweden) and were used with 
PFA fixation. 
Protein Dilution 
STX5 1:45 
GPRC5A 1:69 
RP11-49K24 1:6 
ACBD3 1:54 
WDR45L 1:40 
LRBA 1:100 
RASSF6 1:9 
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COPG1 1:50 
TMCO3 1:98 
BET1L 1:200 
DENND4B 1:104 
GOLGA5 1:69 
GOLIM4  1:10 
AKAP9 1:222 
TMF1 1:72 
GOLM1  1:32 
B4GALT1  1:10 
GOLGB1 1:90 
MANEA 1:30 
GALNT2  1:19 
PDE4DIP  1:10 
SYNGR2 1:87 
CCDC146 1:200 
GCC1 1:100 
CCDC25 1:20 
BICD2 1:10 
GAK 1:50 
DYRK4 1:106 
PLEKHA3 1:169 
GORASP2 1:43 
RASGEF1A 1:159 
TMEM165  1:88 
USO1  1:31 
SNAPIN 1:65 
TMED10 1:56 
COG8 1:55 
 
6.4.2 Secondary Antibodies 
All the below mentioned secondary antibodies conjugated with AlexaFluor are 
obtained from Molecular probes. 
Protein/Label Host Dilution 
AlexaFluor 488-mouse goat 1:200 
AlexaFluor 568-mouse donkey 1:200 
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AlexaFluor 647-mouse donkey 1:200 
AlexaFluor 647-sheep donkey 1:200 
AlexaFluor 568-rabbit donkey 1:200 
AlexaFluor 647-rabbit donkey 1:200 
AlexaFluor 568-sheep donkey 1:50 
AlexaFluor 568-rabbit goat 1:200 
AlexaFluor 488-mouse chicken 1:200 
 
6.5 Electron Microscopy 
6.5.1 Chemicals 
Chemical Source 
Cacodylic acid (Sodium cacodylate 
trihydrate) 
Sigma-Aldrich 
Malachite green oxalate salt Sigma-Aldrich 
25% Glutaraldehyde in H2O EMS 
Osmium (OsO4, 4% in H2O) Serva 
Sodium citrate dehydrate Merck 
Epon Serva 
Tannic acid EMS 
Uranyl acetate (UA, 2% in 70% Methanol) Serva 
Lead nitrate Sigma 
K3Fe(CN)6 Merck 
Methanol Merck 
Ethanol Merck 
Propylene oxide Merck 
Potassium chloride Merck 
Magnesium chloride Merck 
Calcium chloride Merck 
Sucrose USB corporation 
Epon resin chemicals Serva 
 
 
6.5.2 Fixative and solutions 
All the compositions mentioned in this section are calculated to prepare 10 ml solutions. 
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Solution Composition 
Fixative 1 1 ml of 25% Glutaraldehyde 
0.5 ml of 1 M KCl  
0.26 ml of 0.1 M MgCl2 
0.26 ml of 0.1 M CaCl2 
7.98 ml of 50 mM Cacodylate buffer + 2% Sucrose 
Fixative 2 1 ml of 25% Glutaraldehyde 
0.5 ml of 1% Malachite green 
5 ml of 0.2 M Sodium cacodylate buffer 
3.5 ml of molecular grade distilled water 
Post fixation solution 5 ml of 0.2 M Sodium cacodylate buffer 
2.5 ml of 4% OsO4 
2 ml of 4% K3Fe(CN)6 
0.5 ml of molecular grade distilled water 
Tannic acid solution 0.1 g of Tannic acid 
10 ml of molecular grade distilled H2O 
Mix and filter 
Uranyl acetate solution 0.1 g of Uranyl acetate 
10 ml of molecular grade distilled H2O 
Lead citrate solution 0.266 g of Pb(NO3)2 
0.352 g of Na3(C6H5O7)2H2O 
10 ml of molecular grade distilled H2O 
EPON 812 Mixture A: Glycid ether 100  (62 ml) + DDSA (100 ml) 
Mixture B: Glycid ether 100 (100 ml) + MNA (89 ml) 
EPON resin: Mixture A 3.23 g + Mixture B 8.48 g + 150 µl 
of DMP-30 
Osmium solution 2% OsO4  in 50 mM Cacodylate buffer  
 
6.5.3 Other materials 
Material Source 
Copper-palladium slot grids  Plano 
Capsules EMS 
Oven (Incu-line) VWR 
Ultramicrotome Leica Microsystems 
Diamond knife Diatome 
Forceps (INOX) Dumont 
Biowave Pro TED Pella 
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6.6 Microscopic setups 
6.6.1 Wide field and electron microscopes 
Microscope Source 
Zeiss Axiovert 200 Carl Zeiss 
ScanR (Automated screening) Olympus 
Olympus CutR (with laser nanosurgery 
setup) 
Olympus 
Rapp Optoelectronics 
Biotwin CM120 FEI  
 
6.6.2 Confocal Microscopes 
Microscope Source 
Laser scanning microscope (LSM 780) Carl Zeiss 
2-Photon LSM 780 NLO Carl Zeiss 
Spinning disk Ultraview ERS PerkinElmer 
Spinning disk Ultraview VoX PerkinElmer 
Laser scanning microscope SP5 MSA Leica 
 
6.7 Software tools for data analysis and web tools 
6.7.1 Software tools 
Software Source 
Image J 1.51a Wayne Rasband, National Institutes of Health (NIH), USA 
RStudio 2.1 Free software foundation Inc., Boston, USA 
MatLab R2012a MathWorks Inc. 
Cell Profiler 2.1.1 Broad Institute, Cambridge, USA 
ScanR Olympus, Hamburg, Germany 
 
6.7.2 Web tools 
Source Usage 
Bluegecko (EMBL internal) 
http://bluegecko.embl.de/cgi-bin/ 
siRNA search and screen data 
Life Technologies RNAi Designer siRNA design 
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https://rnaidesigner.thermofisher.com/rnaiexpress/ 
ENSEMBLE BLAST/BLAT 
http://www.ensembl.org/Multi/Tools/Blast 
Oligonucleotide mapping 
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7 Methods 
7.1 Soft Lithography/Microcontact printing 
To perform microcontact printing on coverslips, the first step is to produce PDMS 
stamps containing the desired three-dimensional pattern. These stamps were then used 
to print the fibronectin on the coverslips. 
7.1.1 Production of PDMS stamps 
The layout design for the stamp was done using CleWin software (WieWeb) and it was 
first translated into a 5 inch chromium photolithography mask by Delta Mask V.O.F 
(Enschede). This mask contains the repeated pattern for multiple stamps and was used 
to produce stamps with a silicone elastomer by a positive tone resist process. Poly 
DiMethyl Siloxane (PDMS) stamps were fabricated using a Sylgard 184 kit. The kit 
contains a silicone elastomer base and a curing agent, which were mixed thoroughly in 
a 10:1 ratio. This mixture was then placed in a vacuum desiccator to remove the air 
bubbles, which can otherwise interfere with the pattern. Once the bubbles are 
completely removed, the mixture was poured onto the mask and it is placed in the 
vacuum desiccator for another round of bubble removal. It was then polymerized 
overnight in an oven at 55°C. The polymerized elastomer was peeled off carefully by 
slowly lifting it up taking care not to damage the mask. Individual stamps containing 
6 µm lines were cut out and stored in the fridge at +4°C. These stamps were used to 
print fibronectin on the coverslips and were washed and re-used for several rounds of 
microcontact printing. 
7.1.2 Printing of fibronectin lines on coverslips and seeding cells 
For printing the fibronectin lines on 15 mm glass coverslips, the coverslips were first 
washed with acetone, ethanol and deionised water to remove any dirt from the surface. 
The coverslips were then dried using compressed nitrogen gas. The PDMS stamps were 
pre-incubated with 100 µl of fibronectin solution (50 µg/ml in PBS) for 30 min. To 
perform Laser nanosurgery experiments, a 10 cm hole was drilled in the centre of 
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35 mm petri dish and a 15 mm glass coverslip patterned with fibronectin lines was 
attached. The coverslips were treated with oxygen plasma for 2 min at a power of 2.5 
for an efficient attachment and printing by the PDMS stamps. The stamps were washed 
with deionised water to remove the excess fibronectin and dried using the compressed 
nitrogen gas. These fibronectin-coated stamps were gently placed on the coverslips, 
with the side of the pattern contacting the surface of the coverslip. The stamps were left 
to transfer the fibronectin onto the coverslips for 10 min. After incubation, the stamps 
were carefully removed and washed with ethanol and water. They were dried and 
stored at +4°C for later use. The coverslips were now incubated with 100 µl of Poly L-
Lysine-g-Poly Ethylene Glycol (PLL-g-PEG) (1 mg/ml) diluted 1:100 in PBS for 30-
45 min. The coverslips were washed twice in PBS by dipping it in and out in a 50 ml 
falcon tube as quickly as possible, while keeping in mind the patterned side. This 
allows the water film to reach the bottom of the coverslip, leaving the rest of the 
coverslip dry. The remaining small droplet of water can be removed carefully by using 
a soft tissue without touching the region with the pattern. These coverslips were placed 
individually in 3 cm petri dishes with the fibronectin pattern facing upwards and stored 
at +4°C for a couple of weeks. To glue these coverslips to a 35 mm dishes, 10 mm holes 
were drilled in the centre. The coverslips were glued to the bottom these dishes with the 
help of Glisseal (grease) and nail polish (to ensure the stability). These dishes are 
allowed to dry for a few minutes and then used to seed cells. 
 
7.2 Cell biology 
7.2.1 Cell culture 
All the material used for the cell culture must be sterile to prevent any contamination of 
the cells. BSC1-GalT-GFP2 cells were cultured in MEM medium supplemented with 
10% FCS, 1% L-Glutamine and 400 µg/ml of fresh Geneticin at 37°C in 5% CO2. 
Geneticin is added in order to maintain the selection pressure for the GalT-GFP2 
positive clones. The cells were continuously passaged once they reach 80% confluence, 
until 25 passages. To do this, the cells were washed once with 2.5 ml of trypsin-EDTA 
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solution and incubated with 2 ml of the same in the incubator for a few minutes till the 
cells detach. Once the cells detach, 8 ml of the supplemented medium was added to 
saturate the trypsin. The cells were then pipetted in and out of the petri dish a few 
times, to de-clump them. These cells were seeded into a new 10 cm petri dish according 
to desired confluence and need for the experiments (1:2, 1:5, 1:10). 
HeLa-GalNac-GFP cells were cultured in low glucose (1 g/l) DMEM supplemented with 
10% FCS, 1% L-Glutamine and 400 µg/ml of fresh Geneticin at 37°C in 5% CO2. The cells 
were passaged continuously for 20 passages in a similar way as in the case of BSC1-
GalT-GFP2 cells. 
7.2.2 Plating cells 
The cells were counted and plated on coverslips or glass bottomed dishes depending on 
the duration of the experiment and the size of the dish. The following tables show 
number of BSC1-GalT-GFP2 cells plated for different durations of knockdown in a 
MatTek dish with a total volume of 2.5 ml as well as the number of cells seeded in a 4 
well Labtech with a total volume of 900 µl. To perform Laser nanosurgery experiments 
the following day, BSC1-GalT-GFP2 cells were counted and 10×104 cells were seeded on 
a 35 mm dish prepared by gluing a 15 mm patterned coverslip (see 7.1.2).  
 
Dish size Number of cells Knockdown duration 
35 mm 1.5×104 96 h 
35 mm 3×104 72 h 
35 mm 6×104 48 h 
 
Labtech Number of cells Knockdown duration 
4 well 0.7×104 96 h 
4 well 1.2×104 72 h 
4 well 2.2×104 48 h 
 
7.2.3 Freezing and thawing cells 
The cells were frozen and stored in liquid nitrogen to maintain stocks for later use. In 
order to freeze the cells, the freezing media was prepared and stored at +4°C. The cells 
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were detached from 10 cm confluent petri dishes using trypsin-EDTA and were re-
suspended (see 7.2.1) into 15 ml falcon tubes.  The cells were centrifuged at 1000 rpm 
for 5 min in a centrifuge (5804R) to obtain a cell pellet. After carefully removing the 
supernatant, the cell pellet was re-suspended in 0.5 ml of cold FCS and 0.5 ml of cold 
freezing media. This mixture was carefully transferred into pre-chilled cryotubes. The 
cryotubes were transferred into a cell freezing container which promotes slow freezing 
of the cells. The container was immediately stored at -80°C for 1-2 days before 
transferring into the liquid nitrogen container (-160°C) for long-term storage.  
To thaw a frozen vial of cells, the cryotubes were placed in a 37°C water bath with the 
help of a float, taking care not to immerse or contact the lid with the water. After 
quickly thawing the cells, they were transferred into a 15 ml falcon tube containing 9 ml 
of pre-warmed medium supplemented with FCS and L-Glutamine (see 7.2.1). These 
tubes containing cells were further centrifuged at 1000 rpm for 5 min and the 
supernatant containing DMSO was carefully removed leaving the cell pellet in the tube. 
The cells were further suspended in 10 ml of complete medium and transferred and 
distributed into a 10 cm petri dish.  These cells were passaged at least three times before 
using them to perform any experiments. 
7.2.4 Transfection of eukaryotic cells 
To inhibit the re-synthesis of selective proteins and thus to obtain a gene knockdown, 
the cells were transfected with small interfering RNAs (siRNAs). To perform the 
transfections, the required numbers of cells were seeded onto a 35 mm MatTek dish or a 
35 mm dish with a fibronectin-patterned coverslip (see 7.1.2) the day before (see 7.2.2).  
The transfection protocol involves the preparation of two separate solution mixtures 
and incubating them for 5 min. The contents of the mixture 1 were transferred into the 
tube containing mixture 2 and the resulting solution was incubated for 20 min. Mean 
while the MEM/DMEM complete medium of the cells was washed and replaced with 
the MEM/DMEM growth medium (without FCS) and placed back in the incubator at 
37°C and 5% CO2. After the incubation, the MEM/DMEM growth medium (without 
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FCS) was replaced with 200 µl of the same medium and the transfection mixture was 
carefully added dropwise.   
The following table shows the compositions of mixture 1 and 2 used for transfection. 
   
Dish size 
and volume 
Mixture 1 Mixture 2 Incubation 
time 
35 mm 
(2.5 ml) 
OptiMEM 26 µl 
Oligofectamine 1.5 µl 
Incubate for 5 min 
OptiMEM 70 µl 
siRNA 3.33 µl 
Incubate for 5 min 
Mix.1+Mix.2 
for 20 min  
4 well 
Labtech 
OptiMEM 13 µl 
Oligofectamine 0.75 µl 
Incubate for 5 min 
OptiMEM 35 µl 
siRNA 1.5 µl 
Incubate for 5 min 
Mix.1+Mix.2 
for 20 min 
 
7.2.5 Brefeldin A (BFA) Treatment 
The BSC1-GalT-GFP2 cells were seeded on autoclaved coverslips (~11 mm) placed in a 
10 cm dish the day before in a 1:2 ratio from a confluent dish. BFA (1:1000) was diluted 
into MEM complete medium in a 15 ml falcon tube the following day. The MEM 
complete medium was removed and replaced with the medium containing BFA. The 
cells were placed back into the incubator for 30 min. After the incubation, the medium 
was removed and the cells were washed with PBS and fixed with 3% PFA (see 7.2.6). 
The individual coverslips were then stained for different proteins, markers and 
mounted onto the glass slides with Mowiol for imaging. 
7.2.6 Immunofluorescence 
The cells seeded on petri dishes or coverslips were fixed with 3% PFA for 20 min.  To 
permeabilize the cells, saponin solution (0.1% Saponin and 10% FCS in PBS) was used. 
One or more primary antibodies were diluted in saponin solution and incubated for 
1 hr in a humid chamber. The cells were washed thrice with PBS with a 3 min time 
interval. The cells were subsequently stained with one or more secondary antibodies 
(tagged a fluorescent molecule e.g. AlexaFluor), which were also diluted in saponin 
solution and this was incubated for 1 hr. This was followed by another round of 
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washing with PBS three times with a 3 min time interval. The cells were subsequently 
treated with Hoechst (dilution 1:5000) for 5 min to stain the nuclei. The coverslips were 
further rinsed twice with PBS and mounted onto glass slides with Mowiol and allowed 
to dry overnight on the bench or for 30 min in the incubator (37°C). In case of petri 
dishes, the cells were washed and imaged directly in PBS without the need for 
mounting. The samples can be stored at +4°C for a couple of days for imaging.  
 
7.3 Laser nanosurgery and Microscopy 
For performing laser nanosurgery to deplete the Golgi, the laser must be optimized, 
calibrated and the cells showing a displaced Golgi from the nucleus must be identified.  
7.3.1 Calibration of laser nanosurgery system 
To perform a successful laser nanosurgery, the x,y plane of the laser must be calibrated 
or aligned to the x,y plane of the field of view. This must be done using the same 
objective, which will be later used for laser nano surgery experiments. To perform this, 
a 35 mm glass bottomed petri dish was used and an area without cells was selected. For 
the calibration, the Rapp UGA software was switched to calibration mode, which 
generates small circles along the four corners of the screen sequentially. Using the keys 
of the keyboard the laser scanner must be moved to the centre of these displayed 
circles. After the calibration of these borders of the field of view, the software generates 
16 points evenly distributed in the field of view. The laser scanner must be moved to 
these points, which allows the software to determine the deviations between the aimed 
position and the actual position of the laser spot. Once the calibration is successfully 
done, it can be saved and re-used for several days. To quickly check if the laser is still 
properly calibrated, the glass can be etched and compared with the drawn pattern (see 
7.3.3).  
7.3.2 Laser nanosurgery to deplete the Golgi apparatus from the cell 
Once the laser calibration is checked, the cells showing a displaced Golgi from the 
nucleus must be identified from the dish. The laser nanosurgery was performed with a 
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60X water immersion objective (1.2 NA) at 1% of the total laser power. An image of the 
cell was taken with both the GFP channel and the transmission to visualize the Golgi 
and the nucleus. A line was drawn perpendicular to the axis of the cell between the 
nucleus and the Golgi using Rapp UGA software. The laser nanosurgery was 
performed in multiple cycles by moving the z-focus position from the top of the cell to 
the bottom in 3-4 s, having the laser on 1% power. This allows the disruption of actin 
cytoskeleton and as a result in the separation of the cell into two parts by thinning and 
closing the membrane. These cycles were repeated by giving a 1 min interval for the cell 
to recover. This was done till the Golgi is depleted from the cell.  
7.3.3 Laser inscription for tracing back the cells 
After performing a successful laser nanosurgery and depleting the Golgi from the cell, 
one can loose track of the cell if the dish is accidentally touched or moved. It will be 
very difficult to trace back the cell by looking and going through the entire dish. It is 
also difficult to trace back the cell after performing Immunofluorescence or other 
treatments. So the region of these cells of interest must be marked few minutes after the 
laser nanosurgery. This was done by inscribing a rectangle in the field of view of the 
cell of interest, inside the coverslip. This was done with a 3% laser power, while making 
sure to focus the laser inside the glass coverslip (by verifying that the cells are out of 
focus while performing the etching). This is particularly important because focusing the 
laser on outer surface of the coverslip can damage or even kill the cells of interest. The 
inscribed pattern was used to find back the cells of interest.   
7.3.4 Time lapse imaging of the karyoplast 
The karyoplasts were allowed to recover for 2 hr after the laser nanosurgery and then 
followed by time-lapse imaging. The time-lapse imaging was performed with the help 
of Cell^R or Xcellence rt software using a 20X (UPlanSAPo, NA 0.75) objective on either 
the Olympus CutR or ScanR equipped with a 37°C environmental box. During the 
acquisition, the chamber was setup to be humid and at 37°C. As the karyoplasts moved 
a lot along the fibronectin lines during the acquisition, a low magnification objective 
(20X) was used instead of a higher magnification. The karyoplasts were imaged every 
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12 min for 20-22 hr time period in transmission and GFP channels. This time resolution 
and magnification were enough to follow the karyoplasts and to quantify the newly 
formed fluorescent structures during the Golgi biogenesis process. At the end of the 
timelapse, the cells are either fixed with 3% PFA for staining with antibodies for 
different proteins or fixed for performing CLEM. 
7.3.5 Wide field imaging of fixed cells 
After performing the immuno-staining to label different proteins in the cell, they were 
imaged using a Zeiss axiovert 200 widefield microscope or ScanR. The images were 
acquired using either 40X/NA 1.3 oil immersion objective or 63X/NA 1.4 oil immersion 
objective. The images of the VSVG assay were acquired using ScanR using a 20X air 
objective. 
7.3.6 Confocal imaging of fixed cells 
The confocal imaging of fluorescently labelled Golgi, mitotic cells and BFA treated cells 
were performed using the following microscopes. Zeiss LSM780 or LSM780 NLO, 
Perkin Elmer Ultraview ERS or VOX and Leica SP5 MA. Z-stacks were acquired to 
cover the entire cell while imaging.  
7.3.7 Automated imaging of Mitotic cells 
I used adaptive feedback microscopy (Tischer et al. 2014) to identify cells in the early 
stages of mitosis (pro-metaphase) similar to previous publication method (Conrad et al. 
2011). Online image analysis used to classify cells was based on supervised machine 
learning trained by example. The imaging was done using a confocal microscope SP5A 
with the HCS software extension (or matrix screener). We set up a low magnification 
pre-scan (512×512 and zoom: 1X) and these images were analysed online using the Cell 
cognition software package (Held et al. 2010). This cell cognition software package 
includes a classifier that needs to be trained beforehand with a training set of images, in 
order to identify the cells of interest.  
To do so, images were acquired for 24 hr with HeLa-GalNacT2-GFP H2B-mCherry 
expressing stable cell line with the low magnification pre-scan. These set of images were 
used to train the classifier in Cell cognition software for pro-metaphase during mitosis. 
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This was done by picking positive and negative examples of cells and annotating them 
to two different classes. Cells showing a condensing DNA to enter metaphase were 
picked and annotated as pro-metaphase and all other cells showing interphase 
morphology, dead cells etc., were annotated as others. After successful annotation and 
training of the software with good number of examples, the training set was saved. The 
communication between Leica matrix screener software and Cell cognition was 
established using a python script similar to previous publication (Hilsenstein 2014). 
Once a mitotic cells are detected, a high magnification (512×512 and zoom: 4X) time-
lapse imaging was started and the mitotic cell was imaged every 2.5 min for 2 channels 
(Golgi and nucleus) with 20 z-slices at a distance of 1 µm for 30 time points. Upon 
completion of the high magnification imaging, the software was set-up to switch back 
to the low magnification mode to find cells of interest. This process was looped and 
images were acquired for 24 hr. The analysis of this time-lapse data is described in 
section (see 7.5.4). 
7.3.8 Correlative light and electron microscopy (CLEM) 
CLEM was used to examine the same sample with fluorescence microscopy and to get 
the details of the ultra structure (of the regions of interest) using electron microscopy. 
Images were acquired using a light microscope prior to chemical fixation for EM. The 
sample was then fixed using chemical fixation protocol for EM. The cell of interest was 
traced back on the light microscope and the surface is etched or removed along a 
desired pattern to generate grooves on the glass coverslip. The sample was further 
processed and embedded into epon resin which generates ridges, helping to easily 
locate the region of interest. (Tängemo et al. 2011) 
7.3.8.1 Cell preparation 
Cells were seeded the day before the experiment on 35 mm dishes glued with glass 
coverslip at the bottom (see 7.1.2) in a low FCS medium.  The cells were transfected 
with siRNA (to inhibit the re-synthesis of the selected proteins) 5 hr before the laser 
nanosurgery. After 4 hr medium was replaced by CO2  independent medium with 10% 
FCS, which allows cells to migrate resulting in a displacement of the Golgi from the 
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nucleus. The laser nanosurgery was performed on cells and they were imaged till a 
desired time point was reached. At the end of the time-lapse, the cells were imaged in 
the GFP channel with a 60X water immersion objective. The cells were then fixed 
following either of the EM fixation protocol mentioned below. 
7.3.8.2 EM fixation protocol 
All the below steps were performed in a Biowave Pro without the lid of the petri dish 
containing cells.  
1. The cells were fixed with Fixative 1 in the Biowave Pro for 14 min under vacuum 
and a power of 0 watts and 100 watts alternating between two minute cycles. 
2. They were rinsed twice with 50 mM Cacodylate buffer and put back in the 
Biowave Pro for 80 s at a power of 250 watts under vacuum. 
3. The etching of the coverslip surface was either performed at this step or at a later 
step mentioned below. The cells were traced back on the light microscope and 
the surface of the coverslip was etched to form grooves.  
4. The mixture A of epon resin was prepared by adding all the chemicals and 
placing it on a magnetic stirrer. Once these contents were mixed well, mixture B 
was also added and left stirring. The speed of the magnetic stirrer was kept low 
to avoid formation of any air bubbles.  
5. The cells were further treated with osmium solution and placed back in the 
Biowave Pro for 14 min under vacuum and a power of 0 watts and 150 watts 
alternating between two minute cycles. 
6. The cells were rinsed twice with water and put back in the Biowave Pro for 80 s 
at a power of 250 watts under vacuum. 
7. The etching of the coverslip could also be performed at this step. The cells were 
treated with UA solution for 7 min under vacuum and a power of 0 watts and 
150 watts alternating between one minute cycles. 
8. Subsequently, the cells were washed twice with water and put back in the 
Biowave Pro for 80 s at a power of 250 watts under vacuum. 
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9. The cells were dehydrated using different concentrations of ethanol (25%, 50%, 
75%, 90%, 100% and 100%) slowly and sequentially under vacuum for 40 s in 
each concentration at a power of 250 watts. 
10. The coverslips were carefully detached from the 35 mm dish or a 35 mm MatTek 
while immersing them into the 100% ethanol (not to dry out the sample). The 
coverslips were quickly rinsed in propylene oxide and twice in ethanol and 
placed immediately on the pre-prepared epon resin (filled in a capsule) for flat 
embedding. For this step, the coverslip is placed in such a way that the cells were 
in contact with the epon resin. 
11. Making sure the coverslip is in complete contact with the resin, the capsule is 
quickly turned upside down to finally have the coverslip at the bottom with the 
resin on top. Care should be taken not to move the coverslip or allow the resin to 
spill out of the capsule, which might effect the embedding. This allows the air 
bubbles to float up to the top of the capsule without interfering with the 
embedding of the sample.  
12. The sample was left to polymerize at 60°C for 24 hr. Upon polymerization, the 
coverslip was removed from the resin block by using alternate freeze thaw cycles 
in liquid nitrogen and hot water. This results in irregular expansion of the glass 
coverslip, allowing it to break and detach from the resin block. 
7.3.8.3 EM Fixation protocol with Malachite green 
1. The cells were fixed with Fixative 2 in the Biowave Pro for 14 min under vacuum 
and a power of 0 watts and 100 watts alternating between two minute cycles. 
2. They were rinsed twice with 0.1 M Cacodylate buffer and put back in the 
Biowave Pro for 80 s at a power of 250 watts under vacuum. 
3. The etching of the coverslip surface was either performed at this step or at a later 
step mentioned below. The cells were traced back on the light microscope and 
the surface of the coverslip was etched to form grooves.  
4. The mixture A of epon resin was prepared by adding all the chemicals and 
placing it on a magnetic stirrer. Once these contents were mixed well, mixture B 
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was also added and left stirring. The speed of the magnetic stirrer was kept low 
to avoid formation of any air bubbles.  
5. The cells were further treated with Post fixation solution and placed back in the 
Biowave Pro for 14 min under vacuum and a power of 0 watts and 100 watts 
alternating between two minute cycles. 
6. The cells were rinsed twice with Cacodylate buffer and put back in the Biowave 
Pro for 80 s at a power of 250 watts under vacuum. 
7. The cells were treated with Tannic acid solution for 7 min under vacuum and a 
power of 0 watts and 150 watts alternating between one minute cycles.  
8. The cells were again washed twice with Cacodylate buffer and put back in the 
Biowave Pro for 40 s at 250 watts power.  
9. The Cacodylate buffer was replaced with water and placed back in the Biowave 
Pro for 80 s and a power of 250 watts. 
10. The etching of the coverslip could also be performed at this step. The remaining 
steps of the protocol is same as described above from steps 7 to 12. 
7.3.8.4 Etching of the glass coverslip 
To locate the cells of interest after the flat embedding of cells upon EM fixation, the 
coverslip surface was etched by laser. This was done either before treating the cells with 
osmium or before the Uranyl acetate as mentioned in the protocol earlier. Two 
rectangular line patterns were etched on both sides of the cell of interest with a 5% of 
the total laser power. This higher energy (~600 nJ) per pulse result in the formation of 
plasma accompanied by cavitation, which is the formation of transient hypersonic 
bubbles. These bubbles can potentially harm cells in the close proximity (~20 µm). So 
the etching was performed at least 100 µm away from the cells of interest. This ensures 
that the etching of the glass surface will not effect the cells of interest. In case of 
multiple cells, additional lines or patterns were etched to distinguish one cell from the 
other. The etching was done with a 63X/1.2 NA Water objective. 
To perform the etching, the cells of interest were located using the 20X or 10X objective 
lens and the positions were marked using the CellR software. The objective lens was 
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changed to 63X/1.2 NA water and a desired line pattern was drawn at least 100 µm 
away from the cell of interest on one side. The glass was etched with the laser to form 
grooves on the surface. The same was repeated on the other side of the cell. Once the 
etching was done, the objective lens was changed back to 20X and images were taken of 
the entire field of view with the line patterns and the cells. This was used as a map to 
locate the cell of interest upon flat embedding and sectioning the sample. 
7.3.8.5 Trimming and Sectioning of the resin block 
The trimming and sectioning of the resin block was kindly performed by Paolo Ronchi 
(EMBL Heidelberg). The ridges on the polymerized resin blocks help in easily 
identifying the position of the cells using a dissecting microscope. Upon identification 
of these positions, the resin block was trimmed with a razor blade into a trapezoid 
shape, removing the resin around it and just keeping the area of interest with the 
markings. Serial ultrathin sections (thickness 70 nm) were prepared using a Leica UC7 
ultra microtome, which were transferred to copper palladium slot grids (2×1 mm) 
freshly coated with Formvar. The cells fixed without malachite green protocol (see 
7.3.8.2) were contrasted with UA (2% in methanol) and lead citrate. Finally the cells 
were identified based on the cell map from the light microscope and imaged using the 
Transmission Electron Microscope (TEM).  
Note: It was often not possible to trim more than five cells on a single coverslip mark as 
the razor blade or a saw used to trim the block is not precise enough to separate many 
different positions on the resin block.  
7.3.9 Quantification of the time-lapse/Golgi biogenesis 
To analyse and quantify the time-lapse imaging (after laser nanosurgery and during 
mitosis), Image J and Cell profiler were used. And to extract the time taken for different 
phases during the Golgi biogenesis, a Matlab script was used. The cells were segmented 
and images were processed using Image J (see 7.5.2), a cell profiler pipeline (see 7.5.3) 
was used to identify and segment the GalT-GFP2 structures and to quantify the 
fluorescence intensities. MatLab (see 7.5.4) was used to plot the data from the Cell 
profiler and to extract the time taken for different phases of Golgi biogenesis. 
Methods 
 
 106 
7.4 VSVG assay 
VSVG protein from ts045 mutant strain of Vesicular Stomatitis Virus (VSV) has been 
widely used to study membrane transport. This is a temperature sensitive mutant 
which is misfolded, retained in the ER at 40°C and upon temperature shift to 32°C, the 
protein moves out of ER (Beckers, Keller, and Balch 1987; Bergmann 1989; Kreis and 
Lodish 1986). 
In this assay we used YFP tagged VSVG protein from ts045 mutant strain to visualise its 
localization and study protein transport from the ER to Golgi. This was done in control 
cells and cells treated with GRASP65 and 55 siRNA to quantify and measure the 
transport efficiency from ER to Golgi in both cases.  
7.4.1 Protocol for VSVG assay 
1. BSC1 cells (8×104) were seeded in 5 cm petri dishes with coverslips inside.  
2. After 24 hr cells were transfected with control and GRASP65+55 siRNAs in 
individual dishes. 
3. A moist chamber was prepared and a Parafilm was placed inside, to add 
droplets of virus for infection. 
4. Cells were infected with the VSVG-YFP from Vector bio labs by placing 50µl 
drops of diluted virus on a Parafilm and placing individual coverslips on each 
drop.  Cells were incubated with virus for 1 hr at 37°C. 
5. A 12 well plate with cell culture medium was prepared to put each coverslip into 
individual wells after infection. Coverslips were transferred to the 12 well plate. 
6. Cells were washed with 2 ml of medium to remove any residual virus and 12 
well plate was placed at 37°C for 20 min. 
7. Plates were transferred to 40°C and leave it for 16-18 h. 
8. After the incubation, 2 µl of Cyclohexamide (dilution 1:1000) and 50 µl of HEPES 
buffer (25mM) was added to the individual wells and incubated at 32°C 
according to respective release times (20 min) to stop new protein synthesis and 
release the existing protein from the ER. The cells with zero time point were 
immediately fixed without the addition of Cyclohexamide.  
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9. Cells were fixed with 3% PFA (20 min) and permeabilise with Saponin (0.1%) 
and FCS (10%). Immuno-staining was performed with anti mouse GM130 
primary antibody for 45 min followed by washing with PBS and staining with 
Secondary antibody  (tagged with Alexa Flour 568).  
10.  Nucleus was stained with Hoechst (dilution 1:5000) for 5 min. Coverslips were 
mounted with Mowiol and dried at room temperature overnight. The samples 
were then imaged using ScanR microscope. 
 
7.5 Computational Biology 
7.5.1 Image Analysis 
7.5.2 Image J 
Image J was used to visualize all the images acquired for different experiments. 
7.5.2.1 Analysis of Golgi biogenesis 
To analyse the increase in the fluorescence intensity of the GalT-GFP2 structures, the 
GFP channel of the time-lapse was loaded into Image J. A mask was drawn around the 
cell of interest for each frame of the time-lapse and the images were named as mask and 
saved as an image sequence. A mask was drawn for the background (without any cells) 
by z-projecting all the frames of the time-lapse, named as BG and saved as an image 
sequence. The time-lapse of the GalT-GFP2 channel was also saved as an image 
sequence containing GFP in the name. These images were further analysed by Cell 
Profiler. 
The z-stacks from obtained from confocal imaging were sum projected for the GFP 
channel for Golgi. Then masks for background and cell were created in the same way as 
mentioned above. Also the time-lapse was saved as an image sequence as mentioned 
earlier. These images were further analysed by Cell profiler with an additional module 
to convert the 32-bit images to 8-bit. 
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7.5.2.2 Analysis upon Brefeldin A treatment  
For the Co-localization analysis with Golgi matrix, Golgi enzyme or TGN/Centrosome 
upon BFA treatment the confocal images were loaded into the software and z-stacks 
were projected with maximum intensity.  
7.5.2.3 Quantification of luminal width of Golgi cisternae 
To quantify the changes in the morphology of Golgi cisternae upon double depletion of 
GRASP55 and GRASP65, we measure the maximum luminal width of the Golgi 
cisternae. The scale bar of EM images was used to find the unit length in the image and 
the line tool in Image J was used to obtain the maximum luminal width by measuring 
number of units (Lee et al. 2014). The maximum luminal width was converted to 
nanometres based on unit length in the image. 
7.5.3 Cell Profiler 
7.5.3.1 Analysis of Golgi biogenesis 
The image sequences saved in the input folder from Image J (see 7.5.2.1) were analysed 
by a Cell Profiler pipeline developed by Christian Tischer (EMBL Heidelberg). The Cell 
Profiler pipeline contains different modules, which perform different tasks. The 
following is a brief workflow of the Golgi biogenesis pipeline.  
A LoadImages module loads all the images from the selected input folder. The module 
EnhanceOrSuppressFeatures was used to enhance the fluorescent signal of the particles 
using a tophat filter by subtracting the local background. The module 
IdentifyPrimaryObjects was used to identify the background from the images with 
background mask. The fluorescent signal and the background were measured using 
MeasureImageIntensity module. The background subtraction was done using the 
ImageMath module. IdentifyPrimaryObjects module identifies the objects within the cell 
outline using the mask created by the user. The Crop module crops the region with the 
cell outline. The primary objects or dots were identified from the cropped cell using 
IdentifyPrimaryObjects. The threshold parameters in this module were adjusted and 
verified according to the intensity of the structures. The dots or objects size was 
measured using MeasureObjectSizeShape module and the objects were filtered based on 
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their size as small dots and big dots using two FilterObjects modules. The identified 
objects were converted into image using ConvertObjectsToImage module and the 
intensity values in the image were rescaled to stretch the intensity to its full range using 
RescaleIntensity. The outlines of the big and small dots were overlaid onto the image 
using OverlayOutlines module. These images were saved in a tile format with the 
rescaled gfp image, the gfp overlay image with identified objects/dots, mask outlines 
for cell and background and the image with all identified dots using Tile and SaveImages 
modules. The object intensities, size and shape were measured and they were assigned 
back to the objects using MeasureObjectIntensity, MeasureObjectSizeShape and 
RelateObjects modules respectively. Finally the measured parameters were exported and 
saved as a .csv file as individual files for cell, image, smalldots and big dots. This data 
was further normalized and plotted using MatLab. The following is the general cell 
profiler pipeline used to analyse the structures formed during the Golgi biogenesis.  
LoadImages 
EnhanceOrSuppressFeatures 
IdentifyPrimaryObjects 
MeasureImageIntensity 
ImageMath 
IdentifyPrimaryObjects 
Crop 
IdentifyPrimaryObjects 
MeasureObjectSizeShape 
FilterObjects 
FilterObjects 
ConvertObjectsToImage 
RescaleIntensity 
OverlayOutlines 
Tile 
SaveImages 
MeasureObjectIntensity 
MeasureObjectIntensity 
MeasureObjectSizeShape 
RelateObjects 
RelateObjects 
RelateObjects 
ExportToSpreadsheet 
ExportToSpreadsheet 
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A cell profiler pipeline with same  modules was used to segment structures in mitotic 
cells.  
7.5.3.2 Analysis of ER to Golgi transport by VSVG assay 
The images obtained from the VSVG assay were analysed by a Cell Profiler pipeline 
developed by Christian Tischer (EMBL Heidelberg). The following is a brief workflow 
of the Golgi biogenesis pipeline. The images include a DAPI channel stained for 
nucleus, GFP channel with YFP-tagged VSVG and a Cy3 channel containing Golgi 
stained for GM130. 
A LoadImages module loads all the images from the selected input folder by specifying 
names of different channels. The intensity values in the image were rescaled to stretch 
the intensity to its full range using RescaleIntensity by specifying intensity range of the 
image. IdentifyPrimaryObjects module identifies and segments the nuclei from the DAPI 
channel. IdentifySecondaryObjects module expands the specified distance from the 
nucleus to mark approximate cell boundaries. IdentifyPrimaryObjects module identifies 
and segments the Golgi from the Cy3 channel. The background subtraction was done 
using the ImageMath module. The Crop module crops the image to remove the 
incomplete cells on the edges of the image. MaskImage module is used to mask 
identified cells. The fluorescent signal and the background of cells were measured using 
MeasureImageIntensity module. Smooth module is used to smooth the image using a 
Gaussian filter to properly segment the cells. IdentifySecondaryObjects module uses a 
watershed method to find the exact outlines of the cell. MeasureObjectSizeShape module 
is used to measure the size and shape of the segmented cells. DisplayDataOnImage 
displays the segmented cell on the background corrected image with the measured 
area. FilterObjects module is used to exclude improperly segmented or too big cells from 
the analysis also based on size of the nucleus. MeasureObjectSizeshape is applied to 
measure the Golgi size and shape.  expands the specified distance from the nucleus to 
mark approximate cell boundaries. Upon applying proper threshold to remove the 
saturated cells (ApplyThreshold) and filtering improperly segmented Golgi (FilterObjects) 
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the intensities are measured. The Golgi mask from Cy3 channel is applied on the GFP 
channel to identify the Golgi (MaskImage) and the intensities are re-scaled back.  
The outlines of the cell, nucleus and Golgi were overlaid onto the image using 
OverlayOutlines module. These images were saved with the rescaled GFP image, the 
nucleus and Golgi overlay with identified objects/dots, mask outlines for cell using 
SaveImages modules. The objects were assigned to cells using RelateObjects module. 
Briefly, cells are segmented using GFP channel, the Golgi is segmented using Cy3 
channel and the Golgi mask is created. This mask was applied and the fluorescence 
intensity is measured on GFP channel for individual cells. Finally the measured 
parameters were exported and saved as a .csv file with individual cell measurements 
and image measurements. This data was further normalized and plotted using R.  
The following is the general cell profiler pipeline used to measure the amount of VSVG 
in the Golgi. 
LoadImages 
RescaleIntensity 
RescaleIntensity 
IdentifyPrimaryObjects 
IdentifySecondaryObjects 
IdentifyPrimaryObjects 
MeasureImageQuality 
ImageMath 
Crop 
MaskImage 
MeasureImageIntensity 
Smooth 
IdentifySecondaryObjects 
MeasureObjectSizeShape 
DisplayDataOnImage 
FilterObjects 
MeasureObjectSizeShape 
DisplayDataOnImage 
FilterObjects 
ApplyThreshold 
MeasureObjectIntensity 
FilterObjects 
MeasureObjectIntensity 
DisplayDataOnImage 
FilterObjects 
MaskImage 
MeasureObjectIntensity 
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RescaleIntensity 
RescaleIntensity 
RescaleIntensity 
GrayToColor 
OverlayOutlines 
SaveImages 
RelateObjects 
ExportToSpreadsheet 
CreateBatchFiles 
 
7.5.4 MatLab 
The duration of phase 1 and phase 2 were extracted through a MatLab script developed 
by Aliaksandr Halavati (EMBL Heidelberg). The following is a brief outline of MatLab 
script used for the analysis of multiple .csv files containing data from Golgi biogenesis 
of single cells with different protein depletions. The first part of the script choose files to 
iterate clears all the existing data in the MatLab and then it goes to the specified path to 
load the files. In Make a new file to record summary, it makes a new excel file to save the 
extracted values called Analysis summary. In the next step perform calculations it 
calculates the t1, t2, t1s and t2s which are the durations of phase1, phase2 from raw 
values and smoothed values respectively.  
These values are calculated using a function called “Total Variation Regularized 
Numerical Differentiation” (TVDiff). This function deals with the noisy data. It 
regularizes the differentiation process to avoid the noise amplification of finite-
difference methods. So total variation regularization is used and it allows for 
discontinuous solutions. The resulting algorithm accurately differentiates noisy 
functions, including the ones that have a discontinuous derivative (reference paper rick 
chartrand). The parameters regularization factor and number of iterations must be 
adjusted based on the data. In this section, the data is imported (data import) from the 
table and the intensity of the post-ER structures or Golgi precursors is obtained by 
multiplying the number by the mean integrated intensity of the segmented structures. 
In the next section, calculations are performed to obtain the regularized differentiation 
values. These values are further integrated (integration) and the switching points of 
different phases were obtained from Getting switch time points. These switching points 
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and the derivatives with raw and smoothed values are plotted in a single plot by the 
commands in plotting. 
In the script for multiple analysis, the above mentioned function is looped to perform 
the same calculations for all the files in the folder. At the end the values of the t1, t2, t1s 
and t2s are saved in the excel file created as the Analysis summary.  
 
 
Multiple file analysis 
clear 
%% choose files to iterate 
dir_pth='Z:\vegesna\Bsc1_GalT_cut_cells\12. GR65(01+02)_new'; %path to the input directory 
d = dir(fullfile(dir_pth,'*.csv')); 
nfiles=length(d); 
 
%% Make a new file to record summary 
outTblPth=fullfile(dir_pth,'AnalysisSummary.xls'); 
header={'DataName', 't1raw', 't2raw', 't1smooth', 't2smooth'}; 
if (exist(outTblPth,'file')==2) 
    delete (outTblPth); 
end 
xlswrite(outTblPth,header,'Analysis Summary','A1') 
 
%% perform calculations 
for k = 1:nfiles 
    close all 
   filenm=d(k).name; 
    [t1, t2, t1s, t2s]=Niki_analysis_individualfiles_func(dir_pth,filenm); 
    writeOutput={filenm t1 t2 t1s t2s}; 
    xlswrite(outTblPth,writeOutput,'Analysis Summary',strcat('A',num2str(k+1))) 
    %save plot 
    [a, nm2, b]=fileparts(filenm); 
    set(gcf, 'PaperUnits', 'points'); 
    set(gcf, 'PaperSize', [1000 1000]); 
    set(gcf, 'PaperPositionMode', 'manual'); 
    set(gcf, 'PaperPosition', [0 0 1000 1000]); 
    set(gcf, 'renderer', 'painters'); 
    print(gcf,'-dpdf',fullfile(dir_pth,strcat(nm2,'.pdf'))); 
end 
fprintf('DONE!!!\n\n\n') 
 
Function used  
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function [tPhase1,tPhase2,tPhase1Sm,tPhase2Sm]=Niki_analysis_individualfiles_func(dpath, dfnm) 
    %% Default Parameters 
    %Parameters of TVDiff method (robust derivative calculation) 
    regAlpha=0.02; %regularisation factor 
    nIter=100; %number of iterations for total variance regularisation 
    ep=1e-9;    %division by 0 parameter 
    navg=15; %how many points to take for the moving average 
    %Parameters of AnalyseEdges function (finding switching timepoints) 
    scales=[1 2 4]; 
    thresholds=0.2*ones(1,length(scales)); 
    tranrad=4; 
    if (nargin==2) 
       dt_pth=dpath; 
        dt_fnm=dfnm; 
    else 
        % path to the folder and file name. Use only if not provided by 
        % function arfuments 
        dt_pth='Y:\vegesna\cp_analyse\To plot'; %'Z:/halavaty'%path to the data 
        dt_fnm='cell.csv';                    %data file name 
    end 
    %% add required folders to matlab Path 
    %addpath(dt_pth) 
    addpath('./TVDiff') 
    addpath('./edge_detector_1d') 
   
    %% Data import 
     expd=readtable(fullfile(dt_pth,dt_fnm),'Delimiter',',','ReadVariableNames',true); 
    tVals=(expd{:,1}-1)*12; 
    intensVals=expd{:,5}.*expd{:,8}; 
    intensVals=intensVals/max(intensVals); 
    intensVals(isnan(intensVals)) = 0 ; 
    [nVals, xx]=size(intensVals); 
    intensValsSmooth=conv(intensVals,repmat(1/navg,navg,1),'valid'); 
    tValsSmooth=tVals(((navg+1)/2):(nVals-(navg-1)/2)); 
 
    %% Calculations 
    tsteps=diff(tVals); 
    tsteps=vertcat(tsteps(1), tsteps); 
    tstepsSmooth=tsteps(((navg+1)/2):(nVals-(navg-1)/2)); 
    tvDerVals = TVRegDiff( intensVals, nIter, regAlpha, [], 'small', ep, [], 0, 1 ); 
    tvDerVals=tvDerVals(2:end); 
    tvDerVals=tvDerVals/nVals; 
    tvDerVals=tvDerVals./tsteps; 
    tvDerValsSmooth = TVRegDiff( intensValsSmooth, nIter, regAlpha, [], 'small', ep, [], 0, 1 ); 
    tvDerValsSmooth=tvDerValsSmooth(2:end); 
    tvDerValsSmooth=tvDerValsSmooth/(nVals-navg+1); 
    tvDerValsSmooth=tvDerValsSmooth./tstepsSmooth; 
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    %% Integration 
    restorVals=cumsum(tvDerVals.*tsteps)+intensVals(1); 
    restorValsSmooth=cumsum(tvDerValsSmooth.*tstepsSmooth)+intensValsSmooth(1); 
 
%% Getting switch time points 
    function [tSwitch1,grRate1,tSwitch2,grRate2]= getSwitchPoints(dVals,tVals) 
        %initial values are 0 to find those that were not defined 
        tSwitch1=0; 
        grRate1=0; 
        tSwitch2=0; 
        grRate2=0; 
         [dDifs, minmax, stats] = AnalyzeEdges_AH(dVals, scales, thresholds,tsteps(1), tVals(1), 
tVals(end), tranrad); 
        tSwitch=tVals(minmax>0); 
        nSwitch=length(tSwitch); 
        if(nSwitch>0) 
            if (nSwitch==1) 
                if (stats(1,1)<stats(2,1)) 
                    tSwitch1=tSwitch(1); 
                    grRate1=stats(1,1); 
                else 
                    tSwitch2=tSwitch(1); 
                    grRate2=stats(1,1); 
                 end; 
            else % nSwitch>1 
                if (stats(1,1)<stats(2,1)) 
                    tSwitch1=tSwitch(1); 
                    grRate1=stats(1,1); 
                    tSwitch2=tSwitch(2); 
                    grRate2=stats(2,1); 
                else 
                    tSwitch2=tSwitch(1); 
                    grRate2=stats(1,1); 
                end; 
            end; 
        end; 
    end 
 [tPhase1,grRate1,tPhase2,grRate2]= getSwitchPoints(tvDerVals,tVals); 
    [tPhase1Sm,grRate1Sm,tPhase2Sm,grRate2Sm]= getSwitchPoints(tvDerValsSmooth,tValsSmooth) 
 
%% Plotting 
    function []=putSwitchLabels(tPh1, tPh2) 
        yl=ylim; 
        hold on 
        if(tPh1>0) 
            line([tPh1 tPh1],yl,'Color','r'); 
        end; 
        if(tPh2>0) 
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            line([tPh2 tPh2],yl,'Color','m'); 
        end; 
        hold off 
    end 
    fg=figure( 'Position', [ 100, 100, 800, 800 ] ); 
    subplot(3,2,1) 
    plot(tVals,intensVals,'LineWidth',2); 
    putSwitchLabels(tPhase1, tPhase2) 
    subplot(3,2,3) 
    plot(tVals,tvDerVals,'LineWidth',2); 
    putSwitchLabels(tPhase1, tPhase2) 
      subplot(3,2,5) 
    plot(tVals,intensVals,'LineWidth',2); 
    putSwitchLabels(tPhase1, tPhase2) 
    hold on 
    plot(tVals,restorVals,'-b','LineWidth',3); 
    hold off 
    subplot(3,2,2) 
   plot(tValsSmooth,intensValsSmooth,'LineWidth',2); 
    putSwitchLabels(tPhase1Sm, tPhase2Sm) 
    subplot(3,2,4) 
    plot(tValsSmooth,tvDerValsSmooth,'LineWidth',2); 
    putSwitchLabels(tPhase1Sm, tPhase2Sm) 
    subplot(3,2,6) 
    plot(tValsSmooth,intensValsSmooth,'LineWidth',2); 
    putSwitchLabels(tPhase1Sm, tPhase2Sm) 
    hold on 
    plot(tValsSmooth,restorValsSmooth,'-b','LineWidth',3); 
    hold off 
 
    %% Text output 
    fprintf('\n*********************************************************\n'); 
    fprintf('Results of automated phase identification:\n') 
    if (tPhase1>0) 
       fprintf('Phase 1 was identified\n'); 
       fprintf('End of the first phase %g\n',tPhase1); 
       fprintf('Growth rate of the first phase %g\n',grRate1); 
    else 
       fprintf('Phase 1 was not identified\n'); 
    end; 
    if (tPhase2>0) 
      fprintf('Phase 2 was identified\n'); 
      fprintf('End of the second phase %g\n',tPhase2); 
      fprintf('Growth rate of the second phase %g\n',grRate2); 
    else 
        fprintf('Phase 2 was not identified\n'); 
    end; 
end % end of main function 
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A similar script was used to extract the phase 1 of mitosis. As the data obtained in this 
case had sharp increase and decrease in intensities, the script doesn’t use the TVDiff to 
calculate the derivative. Instead the switching points were identified directly from the 
raw data. The following was the script used to extract the duration of phase 1 in mitotic 
cells.  
Matlab script for analysing data of mitotic cells: 
clear 
%% choose files to iterate 
dir_pth='Y:\vegesna\cp_analyse\all_mitosis\diff.columns_2'; %path to the input directory 
d = dir(fullfile(dir_pth,'*.csv')); 
nfiles=length(d); 
 
%% Make a new file to record summary 
outTblPth=fullfile(dir_pth,'AnalysisSummary.xls'); 
header={'DataName', 't1raw', 't2raw', 't1smooth', 't2smooth'}; 
if (exist(outTblPth,'file')==2) 
    delete (outTblPth); 
end 
xlswrite(outTblPth,header,'Analysis Summary','A1') 
 
%% perform calculations 
for k = 1:nfiles 
    close all 
    filenm=d(k).name; 
[t1, t2]=Niki_mitotic_analysis_individualfiles_func(dir_pth,filenm); 
    writeOutput={filenm t1 t2}; 
    xlswrite(outTblPth,writeOutput,'Analysis Summary',strcat('A',num2str(k+1))) 
    %save plot 
    [a, nm2, b]=fileparts(filenm); 
    set(gcf, 'PaperUnits', 'points'); 
    set(gcf, 'PaperSize', [1000 1000]); 
    set(gcf, 'PaperPositionMode', 'manual'); 
    set(gcf, 'PaperPosition', [0 0 500 1000]); 
    set(gcf, 'renderer', 'painters'); 
    print(gcf,'-dpdf',fullfile(dir_pth,strcat(nm2,'.pdf'))); 
end 
fprintf('DONE!!!\n\n\n') 
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7.5.5 R Studio 
7.5.5.1 Plotting the Golgi biogenesis results  
A self written script in R Studio was used to plot the values of T1 and T2-T1 extracted 
from the plot using MatLab script.  
To briefly explain the script, specific packages required for the plot ggplot2, scales, plyr, 
reshape2 and zoo were loaded in the first part. Then the data was loaded from the text 
file and the name of the knockdown was extracted from the table and used as a label for 
x-axis.  The ggplot2 was used to plot the boxplot by specifying maximum y-value, y-
scale, axis label text orientation and font. The mean value for each condition was 
plotted as a dot in centre of the box plot. Finally the plot was saved as a PDF file of a 
specified height and width. 
The following was the script used to plot the duration of Phase 1 (T1).  
# Boxplot script by N V Gayathri Vegesna 
# txt file with two columns knockdown condition and duration of phases  
# quartz() # to test the plot while its open 
library(ggplot2) 
library(scales) 
library(plyr) 
library(reshape2) 
library(zoo) 
data = read.table(file.choose(), header=T, sep="\t") # save excel file as tab delimited text and open it 
#Turn your 'knockdown' column into a character vector 
data$Knockdown <- as.character(data$Knockdown) 
#Then turn it back into an ordered factor 
data$Knockdown <- factor(data$Knockdown, levels=unique(data$Knockdown)) 
pos = position_jitter(w = .1, h = .0) 
q<- ggplot(data, aes(x = Knockdown,  
                     y = Duration.of.Phase1..min.,  
                     group=Knockdown,  
                     # color="black",  
                     ymax= max(Duration.of.Phase1..min.))) +  
  geom_point(position = pos, alpha=0.4, size=2) + # geom_boxplot() 
  coord_cartesian(ylim=c(-20, 1000)) + 
scale_y_continuous(breaks=c(0,100,200,300,400,500,600,700,800,900,1000))+ 
  geom_boxplot(outlier.shape = NA, alpha=0.5)+stat_summary(fun.y=mean, geom="point", 
colour="black",size=2.5)+ 
  theme(axis.title.x = element_blank()) +   # Remove x-axis label 
  ylab("Duration of Phase 1 (min)") + theme(panel.background = element_rect(fill = "white")) + 
  theme(axis.line = element_line(size = 0.5, colour = "black")) + theme(axis.text.x  = 
element_text(angle=70, vjust=0.5, size=8, colour="black")) 
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# theme(legend.position = "bottom") +                      # Set y-axis label 
pdf(file="q.pdf", width = 6, height = 5) 
print(q)  
dev.off() 
 
The following similar script was used for plotting the duration of Phase 2 (T2-T1).  
# Boxplot script by N V Gayathri Vegesna 
# input txt file with two columns knockdown condition and duration of phases  
# quartz() # to test the plot while its open 
library(ggplot2) 
library(scales) 
library(plyr) 
library(reshape2) 
library(zoo) 
data = read.table(file.choose(), header=T, sep="\t") # save excel file as tab delimited text and open it 
#Turn your 'knockdown' column into a character vector 
data$Knockdown <- as.character(data$Knockdown) 
#Then turn it back into an ordered factor 
data$Knockdown <- factor(data$Knockdown, levels=unique(data$Knockdown)) 
pos = position_jitter(w = .1, h = .0) 
r<- ggplot(data, aes(x = Knockdown,  
                     y = Duration.of.Phase2..min.,  
                     group=Knockdown,  
                     # color="black",  
                     ymax= max(Duration.of.Phase2..min.))) +  
  geom_point(position = pos, alpha=0.4, size=2) + # geom_boxplot() 
  coord_cartesian(ylim=c(-20, 1000)) + 
scale_y_continuous(breaks=c(0,100,200,300,400,500,600,700,800,900,1000))+ 
  geom_boxplot(outlier.shape = NA, alpha=0.5)+stat_summary(fun.y=mean, geom="point", 
colour="black",size=2.5)+ 
  theme(axis.title.x = element_blank()) +   # Remove x-axis label 
  ylab("Duration of Phase 2 (min)") + theme(panel.background = element_rect(fill = "white")) + 
  theme(axis.line = element_line(size = 0.5, colour = "black")) + theme(axis.text.x  = 
element_text(angle=70, vjust=0.5, size=8, colour="black")) 
pdf(file="r.pdf", width = 6, height = 5) 
print(r)  
dev.off() 
 
7.5.5.2 Plotting Golgi biogenesis data from mitotic cells 
The following similar script was used to plot duration of phase 1 in mitotic cells.  
# Boxplot script by N V Gayathri Vegesna 
# input txt file with two columns knockdown condition and duration of phases  
# quartz() # to test the plot while its open 
library(ggplot2) 
library(scales) 
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library(plyr) 
library(reshape2) 
library(zoo) 
data = read.table(file.choose(), header=T, sep="\t") # save excel file as tab delimited text and open it 
#Turn your 'knockdown' column into a character vector 
data$Knockdown <- as.character(data$Knockdown) 
#Then turn it back into an ordered factor 
data$Knockdown <- factor(data$Knockdown, levels=unique(data$Knockdown)) 
pos = position_jitter(w = .1, h = .0) 
r<- ggplot(data, aes(x = Knockdown,  
                     y = Duration.of.Phase1..min.,  
                     group=Knockdown,  
                     # color="black",  
                     ymax= max(Duration.of.Phase1..min.))) +  
  geom_point(position = pos, alpha=0.4, size=2) + # geom_boxplot() 
  coord_cartesian(ylim=c(0,80)) + scale_y_continuous(breaks=c(0,10,20,30,40,50,60,70,80))+ 
  geom_boxplot(outlier.shape = NA, alpha=0.5)+stat_summary(fun.y=mean, geom="point", 
colour="black",size=2)+ 
  theme(axis.title.x = element_blank()) +   # Remove x-axis label 
  ylab("Duration of Phase 1 (min)") + theme(panel.background = element_rect(fill = "white")) + 
  theme(axis.line = element_line(size = 0.5, colour = "black")) + theme(axis.text.x  = 
element_text(angle=70, vjust=0.5, size=8, colour="black")) 
p1=q+theme(axis.line.x = element_line(color="black", size = 1),axis.line.y = element_line(color="black", 
size = 1)) 
pdf(file="p1.pdf", width = 5, height = 5) 
print(p1)  
dev.off() 
 
7.5.5.3 Plotting the data from VSVG assay 
A similar R script using ggplot2 mentioned above was used to plot the individual cell 
data from VSVG assay. The script was used to sort the cells based on experiment and 
time point. Then the ratio of the Golgi integrated FI to integrated FI of total cell was 
calculated for each cell. The values are normalised for zero time point in each condition 
by subtracting the mean of zero time point. The resulting data were plotted as a box 
plot, with the mean represented a dot. The individual experiments were plotted by 
specifying the input file name of the specific experiment. The data from all the 
experiments was pooled together and plotted by specifying input file names of all files 
as comma separated names. 
The following is the R script used for analysis 
rm(list=ls()) 
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library(ggplot2) 
library(scales) 
library(plyr) 
library(reshape2) 
library(zoo) 
 
dataPath<-'/Users/gayathrivegesna/Documents/All_data_analysis/24. VSVG_assay/Tables for analysis' 
inputFileNames<-c('Cells_Exp_1.2.txt','Cells_Exp_1.3.txt','Cells_Exp_4.txt') 
minimal_golgi_ratio<-0.0 
 
#allConditions<-c('Neg9_t0','GRKD_t0','Neg9_t20','GRKD_t20') 
 
timeConditions<-c('t0','t20') 
treatmentConditions<-c('Neg9','GRKD') 
 
data_all<-data.frame() 
for (fileName in inputFileNames){ 
  data_replicate = read.table(file.path(dataPath,fileName), header=T, sep="\t",as.is=TRUE) # save excel 
file as tab delimited text and open it 
  conditions<-do.call(rbind,strsplit(data_replicate$Metadata_siRNA,'_')) 
  data_replicate$Treatment<-factor(conditions[,1],levels=treatmentConditions) 
  data_replicate$Time<-factor(conditions[,2],levels=timeConditions) 
   
  data_replicate$Ratio_Golgi<-
data_replicate$Intensity_IntegratedIntensity_TOTALbgcorrGolgiMask/data_replicate$Intensity_Integra
tedIntensity_TOTALbgcorr 
  data_replicate<-data_replicate[data_replicate$Ratio_Golgi>minimal_golgi_ratio,]#0 
   
  data_replicate_t0<-data_replicate[data_replicate$Time=='t0',] 
  t0_coefficients<-aggregate(Ratio_Golgi~Treatment,data=data_replicate_t0,FUN='median') 
  names(t0_coefficients)[2]<-'t0_value' 
  data_replicate<-merge(x=data_replicate,y=t0_coefficients) 
   
  data_replicate$Ratio_Golgi_t0subtr<-data_replicate$Ratio_Golgi-data_replicate$t0_value 
   
  data_all<-rbind(data_all,data_replicate) 
} 
 
pos = position_jitter(w = .5, h = .0) 
q<- ggplot(data_all, aes(x = Metadata_siRNA,  
                              y = Ratio_Golgi_t0subtr,  
                              #group=Treatment,  
                              # color="black",  
                              ymax= max(Ratio_Golgi_t0subtr))) +  
  geom_point(aes(colour=factor(Metadata_Experiment)),position = pos, alpha=0.4, size=0.3) + 
#coord_cartesian(ylim=c(0, max(data_all_non0$NormalisedValue))) + 
  #scale_y_continuous(trans = 'log10')+# geom_boxplot() 
scale_y_continuous(breaks=c(0,100,200,300,400,500,600,700,800))+ 
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  geom_boxplot(outlier.shape = NA, alpha=0.5)+stat_summary(fun.y=mean, geom="point", 
colour="black",size=2)+ 
  theme(axis.title.x = element_blank()) +   # Remove x-axis label 
  ylab("FI") + theme(panel.background = element_rect(fill = "white")) + 
  theme(axis.line = element_line(size = 0.5, colour = "black")) + theme(axis.text.x  = 
element_text(angle=70, vjust=0.5, size=8, colour="black")) 
# theme(legend.position = "bottom") +                      # Set y-axis label 
p1=q+theme(axis.line.x = element_line(color="black", size = 1),axis.line.y = element_line(color="black", 
size = 1)) 
p1 
pdf(file="p1.pdf", width = 7, height = 5) 
print(p1) 
dev.off() 
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